Examination and observation for other reasons

Z21_EXAM_OBSER_OTH_REASO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z04 Cause of death: ICD-10 — Z04 2 out of 7 registries used, show all original rules.	44201
4. Check minimum number of events None	44201
5. Include endpoints None	44201
6. Filter based on genotype QC (FinnGen only)	42377

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[0-1]

NAME	Z21_EXAM_OBSER_OTH_REASO
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z04
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z04
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Examination and observation for other reasons based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	42377	26800	15577
Unadjusted period prevalence (%)	8.64	9.51	7.14
Median age at first event (years)	54.61	51.88	59.30

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
39138: Matched controls
226397

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.3

323.3

3158

8496

A07EA06

ATC

budesonide; oral, local oral

3.4

322.7

1431

2511

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.4

322.3

1006

1350

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

322.3

4157

12497

A11

ICPC

Chest pain NOS

2.5

321.5

2526

6152

T78.4

ICD-10 Finland

Allergy, unspecified

3.2

321.0

1578

2963

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

320.8

6928

24686

H01

ICPC

Ear pain/earache

2.1

320.3

3917

11539

R96

ICPC

Asthma

2.3

320.1

2895

7527

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

4.1

319.9

1095

1587

EBA00

NOMESCO Finland

Extraction of tooth

1.6

319.4

12268

50790

L16

ICPC

Ankle symptom/complaint

2.1

319.2

3713

10727

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.2

318.3

1065

1515

M01AB05

ATC

diclofenac; systemic, rectal

1.5

317.8

22795

108213

SFA30

NOMESCO Finland

Three-surface restoration

1.6

317.7

13877

59157

N06AX12

ATC

bupropion; oral

2.5

317.7

2473

5995

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.8

317.5

1173

1805

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

316.6

4893

15682

SPAT1216

SPAT

Assessment of functional ability

2.1

316.5

3959

11761

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.2

316.4

3345

9298

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.6

315.6

2192

5018

L02

ICPC

Back symptom/complaint

2.2

315.2

3414

9584

R00.2

ICD-10 Finland

Palpitations

2.5

313.6

2496

6115

C10AC01

ATC

colestyramine; oral

4.3

312.1

1002

1377

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

310.4

6114

21173

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

309.6

4279

13182

A03

ICPC

Fever

1.8

309.4

5907

20261

A98

ICPC

Health maint/preventive medicine

2.4

308.5

37160

200722

K22

ICPC

Risk factor cardiovascular disease

2.9

307.7

1793

3729

R03AC02

ATC

salbutamol; inhalant

1.9

307.7

20179

80121

-69

ICPC

Other reason for encounter NEC

3.9

307.7

1560

2376

N06AB10

ATC

escitalopram; oral

2.1

307.7

7649

23137

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

307.7

3829

10430

XF402

NOMESCO Finland

ECG with work load test

2.4

307.7

2831

7151

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

307.7

5238

12117

XCK00

NOMESCO Finland

Perimetry

3.5

307.7

1784

3077

Z01.8

ICD-10 Finland

Other specified special examinations

9.3

307.7

8220

6308

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

307.7

5466

17205

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

307.7

4796

13855

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

19747

89068

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.5

307.7

2414

5692

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

307.7

7082

20502

R29

ICPC

Respiratory symptom/complaint other

2.7

307.7

2294

5150

L03

ICPC

Low back symptom/complaint

2.1

307.7

9833

31169

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

307.7

3359

7961

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

26.5

307.7

1005

225

A04

ICPC

Weakness/tiredness general

2.6

307.7

5498

13588

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

307.7

2093

4528

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

563.1

307.7

3380

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

15216

50335

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

307.7

6750

22109

XA402

NOMESCO Finland

ENMG

13.8

307.7

1048

449

D02

ICPC

Abdominal pain epigastric

2.8

307.7

2076

4413

Z3226

NOMESCO Finland

Physiotherapist

2.1

307.7

6555

19478

R13

ICD-10 Finland

Dysphagia

3.1

307.7

2286

4422

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.9

307.7

783

581

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.9

307.7

1728

2677

R05

ICPC

Cough

1.9

307.7

8013

26979

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

1218.8

307.7

848

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

307.7

6483

17608

UJF32

NOMESCO Finland

Coloscopy

4.7

307.7

13372

22584

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

307.7

17106

68855

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

307.7

12415

47094

A06AD11

ATC

lactulose; oral

2.1

307.7

4436

12968

AA1AD

NOMESCO Finland

CT of head and brain

2.1

307.7

9034

28046

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

28.7

307.7

2507

539

Z01.1

ICD-10 Finland

Examination of ears and hearing

7.1

307.7

4066

3651

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

307.7

10197

28570

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

307.7

3340

7404

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

307.7

3774

10894

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

35.7

307.7

343

UJF30

NOMESCO Finland

Ileoscopy through colon

4.6

307.7

4757

6654

J01DB01

ATC

cefalexin; oral

2.4

307.7

31847

146739

N05BA04

ATC

oxazepam; oral

2.2

307.7

9381

28109

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

307.7

18739

80858

D01

ICPC

Abdominal pain/cramps general

2.6

307.7

4622

11010

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.6

307.7

2880

6793

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.0

307.7

3128

6317

D11

ICPC

Diarrhoea

2.2

307.7

4332

11880

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

7904

22037

N06AB04

ATC

citalopram; systemic

2.2

307.7

7097

21014

N05AH04

ATC

quetiapine; oral

2.8

307.7

7134

16800

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

307.7

3888

8754

R51.80

ICD-10 Finland

Headache

3.0

307.7

6344

13655

U02

ICPC

Urinary frequency/urgency

2.2

307.7

4419

12514

N30.0

ICD-10 Finland

Acute cystitis

2.1

307.7

5395

15770

S21

ICPC

Skin texture symptom/complaint

2.0

307.7

4663

14387

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.9

307.7

1585

2426

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.8

307.7

7164

16863

R21

ICPC

Throat symptom/complaint

1.8

307.7

7712

26828

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.0

307.7

3657

7572

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

307.7

13063

52728

P01AB01

ATC

metronidazole; oral, rectal

2.0

307.7

14375

51404

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

307.7

7229

23749

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.7

307.7

2398

5427

N05BA01

ATC

diazepam; systemic, rectal

2.3

307.7

4287

11648

A02BC02

ATC

pantoprazole; systemic

2.6

307.7

26172

99250

N02AX02

ATC

tramadol; systemic, rectal

2.4

307.7

16699

53790

N03AX12

ATC

[U] gabapentin; oral

2.8

307.7

5803

13234

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

307.7

7161

22046

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.4

307.7

4275

11171

N06AB06

ATC

sertraline; oral

2.4

307.7

4018

10336

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

307.7

5708

17712

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.6

307.7

3017

7015

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

307.7

6082

20686

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.0

307.7

2596

5247

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

26.4

307.7

2781

654

R06AE07

ATC

cetirizine; oral

1.7

307.7

15568

62714

N02AA05

ATC

oxycodone; systemic

2.1

307.7

5262

15736

N05CF01

ATC

zopiclone; oral

2.0

307.7

10924

36769

N06AX16

ATC

venlafaxine; oral

2.7

307.7

5322

12633

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

307.7

16221

60456

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

259.3

307.7

28488

2312

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

307.7

2394

5408

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

307.7

9161

33122

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

307.7

8195

27915

P01

ICPC

Feeling anxious/nervous/tense

2.2

307.7

4534

12700

SFA20

NOMESCO Finland

Two-surface restoration

1.6

307.7

20849

93835

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

307.7

2103

4580

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

307.7

8562

28704

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

307.7

3649

10236

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.6

307.7

9542

24699

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

7618

27727

XQ802

NOMESCO Finland

Epicutan test

7.9

307.7

1444

1096

N06AX21

ATC

duloxetine; oral

2.9

307.7

4263

9027

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

34.7

307.7

439

Z50.1

ICD-10 Finland

Other physical therapy

3.7

307.7

1881

3070

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

61.6

307.7

1742

171

E66.8

ICD-10 Finland

Other obesity

2.8

307.7

1932

4075

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

307.7

20270

83341

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

307.7

27270

121821

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

307.7

3485

8547

N03AX16

ATC

[U] pregabalin

2.8

307.7

9066

21738

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

307.7

1574

2819

N06AA09

ATC

amitriptyline; systemic

2.6

307.7

2830

6636

L15

ICPC

Knee symptom/complaint

1.8

307.7

7444

26055

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

307.7

18567

77721

M79.6

ICD-10 Finland

Pain in limb

2.2

307.7

15703

53038

C07AA05

ATC

propranolol; systemic

2.0

307.7

7075

22117

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

12.1

307.7

460

222

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

307.7

5189

15417

Z04.3

ICD-10 Finland

Examination and observation following other accident

417.6

307.7

3426

K30

ICD-10 Finland

Functional dyspepsia

2.7

307.7

4185

9603

N02BF01

ATC

gabapentin; oral

2.6

307.7

2542

5950

DFF00

NOMESCO Finland

Pure tone audiometry

3.2

307.7

2203

4206

XQ800

NOMESCO Finland

Prick test

5.2

307.7

2639

3111

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

307.7

8982

28216

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.0

307.7

1416

1696

J01FF01

ATC

clindamycin; systemic

1.9

307.7

9417

32118

Z00.0

ICD-10 Finland

General medical examination

2.9

307.7

5844

12720

XG410

NOMESCO Finland

Flow-volume spirometry

4.2

307.7

1138

1613

M54.5

ICD-10 Finland

Low back pain

2.2

307.7

13843

44856

WX002

NOMESCO Finland

Sedation and analgesia

2.1

307.7

6542

19971

A28

ICPC

Limited function/disability NOS

2.1

307.7

4784

14121

M25.5

ICD-10 Finland

Pain in joint

2.2

307.7

12049

38009

M54.4

ICD-10 Finland

Lumbago with sciatica

2.3

307.7

6524

17814

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.7

307.7

1660

2644

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.6

307.7

2226

3755

UJF92

NOMESCO Finland

Capsular endoscopy

9.5

307.7

1240

778

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

307.7

3230

7594

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

107.4

307.7

1909

108

Z00.8

ICD-10 Finland

Other general examinations

3.0

307.7

2214

4408

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.6

307.7

609

471

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

3.2

307.7

5446

10742

S29

ICPC

Skin symptom/complaint other

2.2

307.7

6951

19883

C07AB07

ATC

bisoprolol; oral

1.9

307.7

15664

59627

L17

ICPC

Foot/toe symptom/complaint

2.1

307.7

10211

32214

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.9

307.7

2642

5584

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

307.7

2340

5348

J01MA12

ATC

levofloxacin; systemic

1.9

307.7

5835

18772

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

7.4

307.7

5397

4779

R03DC03

ATC

montelukast; oral

2.0

307.7

5436

16787

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

79.1

307.7

7209

644

R52.2

ICD-10 Finland

Other chronic pain

4.0

307.7

1173

1755

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.5

307.7

2568

6209

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.9

307.7

2051

3165

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

307.7

14081

59421

K59.1

ICD-10 Finland

Functional diarrhoea

3.0

307.7

1841

3635

R05

ICD-10 Finland

Cough

2.0

307.7

7201

23028

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

307.7

3488

9664

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

307.7

5422

15979

L08

ICPC

Shoulder symptom/complaint

1.9

307.7

6830

22978

M01AH05

ATC

etoricoxib; oral

1.6

307.7

21355

96760

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

307.7

15686

57208

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

307.7

6811

18976

M54.2

ICD-10 Finland

Cervicalgia

2.5

307.7

2624

6327

Z3231

NOMESCO Finland

Registered nurse

2.2

307.7

9828

29709

C03CA01

ATC

furosemide; systemic

1.8

307.7

8666

30294

N06AX11

ATC

mirtazapine; oral

2.2

307.7

12624

39930

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.8

307.7

2101

4552

J01CA04

ATC

amoxicillin; systemic

1.8

307.7

30675

150776

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

307.7

15314

56682

S06.0

ICD-10 Finland

Concussion

2.4

307.7

3850

9947

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.7

307.7

1533

2454

H02AB04

ATC

methylprednisolone; systemic

2.1

307.7

4657

13417

N02BF02

ATC

pregabalin; oral

3.1

307.7

1985

3897

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.8

307.7

3847

8557

ZXA00

NOMESCO Finland

Right side

1.9

307.7

8738

29436

XF404

NOMESCO Finland

Ambulatory ECG

2.5

307.7

2474

5923

Z71.8

ICD-10 Finland

Other specified counselling

2.0

307.7

10775

36714

TND32

NOMESCO Finland

Custom moulded splint, wrist or hand

7.0

307.7

664

557

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.7

307.7

619

471

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.1

307.7

4027

11505

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

307.7

10721

37472

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.8

307.7

2116

3386

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.6

307.7

1450

2426

R60.0

ICD-10 Finland

Localized oedema

2.2

307.7

3726

10394

R52.9

ICD-10 Finland

Pain, unspecified

2.6

307.7

3500

8244

B01AB05

ATC

enoxaparin; parenteral

2.1

307.7

11237

36045

A99

ICPC

Disease/condition unspecnature/site

2.3

307.7

3101

8227

KMAK, ,

NOMESCO Finland

1.7

307.7

18114

77659

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

307.7

9234

30143

L29

ICPC

Musculoskeletal sympt/complt other

2.6

307.7

2976

6979

R06AX27

ATC

desloratadine; oral

1.6

307.7

9713

37805

N03AX09

ATC

lamotrigine; oral

4.3

307.7

1937

2735

Z2446

NOMESCO Finland

Social worker

2.8

307.7

2398

5117

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

307.7

15863

43420

-, ,

ICD-10 Finland

5.9

307.7

1015

1016

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

12.2

307.7

9044

5461

R11

ICD-10 Finland

Nausea and vomiting

2.8

307.7

3171

6814

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.7

307.7

3894

8983

N01

ICPC

Headache

2.3

307.7

4232

11470

A01

ICPC

Pain general/multiple sites

3.1

307.7

3452

6801

K59.09

ICD-10 Finland

Constipation, unspecified

3.0

307.7

2161

4302

N03AG01

ATC

valproic acid; systemic, rectal

2.8

307.7

1959

4125

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

307.7

12579

47733

S18

ICPC

Laceration/cut

2.1

307.7

16222

57538

ZXD05

NOMESCO Finland

Urgent procedure

2.0

307.7

11610

39913

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

307.7

2210

4588

M79.7

ICD-10 Finland

Fibromyalgia

4.3

307.7

1110

1518

K02.1

ICD-10 Finland

Caries of dentine

1.7

307.7

21659

96391

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.4

307.7

3363

6134

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

307.7

3308

8220

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.3

307.7

5831

16005

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

307.7

3747

10571

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

307.7

9151

26650

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

30.2

307.7

2444

498

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

5.8

307.7

16213

24457

J01CA08

ATC

pivmecillinam; oral

1.6

307.7

12693

51362

L12

ICPC

Hand/finger symptom/complaint

2.1

307.7

5691

17038

R74

ICPC

Upper respiratory infection acute

1.6

307.7

11160

44815

ZXA05

NOMESCO Finland

Left side

1.9

307.7

8091

27211

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

307.7

6977

21814

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.6

307.7

3006

7105

L01

ICPC

Neck symptom/complaint

2.2

307.7

5244

15028

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

48.5

307.7

4412

591

A29

ICPC

General symptom/complaint other

2.8

307.7

4799

10803

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

19.7

307.7

378

112

L04AX01

ATC

azathioprine; systemic

3.5

307.7

1656

2852

E0000UV, ,

ATC

1.8

307.7

14634

57360

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

307.7

3543

8909

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

356.0

307.7

487

M48.0

ICD-10 Finland

Spinal stenosis

2.3

307.7

3568

9510

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

307.7

16764

56641

ZXD10

NOMESCO Finland

Scheduled procedure

2.1

307.7

14591

50330

SAA03

NOMESCO Finland

Extended examination of mouth

1.9

307.7

14471

53978

J01FA06

ATC

roxithromycin; oral

1.6

307.7

13129

53666

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.5

307.7

2578

4492

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

307.7

3253

8152

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.2

307.7

1595

2269

G44.2

ICD-10 Finland

Tension-type headache

2.6

307.7

5083

12483

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.0

307.7

2896

5876

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

307.7

2577

5874

X58

ICD-10 Finland

Exposure to other specified factors

2.3

307.7

5614

15163

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.6

307.7

2359

5486

-1, ,

NOMESCO Finland

1.7

307.7

11365

44264

P29

ICPC

Psychological sympt/compl other

2.6

307.7

2430

5716

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

9376

26529

D06

ICPC

Abdominal pain localized other

2.5

307.7

3115

7474

R03BA02

ATC

budesonide; inhalant

1.9

307.7

5886

19663

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

307.7

6808

22988

Z04.1

ICD-10 Finland

Examination and observation following transport accident

82.2

307.7

574

M54.6

ICD-10 Finland

Pain in thoracic spine

2.5

307.7

2553

6106

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

76.1

307.7

1298

102

J01DA01

ATC

[U] cefalexin

1.6

307.7

21303

98445

A02BC04

ATC

rabeprazole; oral

2.4

307.7

2874

7109

Z01.2

ICD-10 Finland

Dental examination

1.7

307.7

16129

66618

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

307.7

8620

30028

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

307.7

24833

112904

UKC02

NOMESCO Finland

Cystoscopy

2.1

307.7

4765

13981

M79.1

ICD-10 Finland

Myalgia

2.3

307.7

5205

13978

J01EA01

ATC

trimethoprim; systemic

1.9

307.7

8448

28390

UJH02

NOMESCO Finland

Anoscopy

3.6

307.7

1577

2627

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.6

307.7

1821

2355

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

4507

10202

R01AD09

ATC

mometasone; nasal

1.7

307.7

15784

65251

WX290

NOMESCO Finland

Other blockage of nerve

1.6

307.7

16768

73199

Z01.0

ICD-10 Finland

Examination of eyes and vision

15.2

307.7

5698

2513

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

307.7

11338

35687

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.0

307.7

5254

11037

P03

ICPC

Feeling depressed

2.4

307.7

3647

9324

A02BC03

ATC

lansoprazole; oral

2.2

307.7

10109

31034

J01FA10

ATC

azithromycin; systemic

1.6

307.7

20504

92761

N05AH03

ATC

olanzapine; systemic

3.0

307.7

2225

4530

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

307.7

11075

34361

R07.3

ICD-10 Finland

Other chest pain

2.6

307.7

3478

8244

A02BA02

ATC

ranitidine; systemic

2.0

307.7

5853

18447

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.1

307.7

3805

7658

WZA90

NOMESCO Finland

Other medical or dental certificate

1.9

307.7

8450

28225

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

8944

26357

R50.9

ICD-10 Finland

Fever, unspecified

2.2

307.7

5249

14996

J01AA02

ATC

doxycycline; systemic

1.8

307.7

27662

128194

D19

ICPC

Teeth/gum symptom/complaint

1.7

307.7

9685

37398

N02BE01

ATC

paracetamol; systemic, rectal

2.9

307.7

34126

158548

ZY010

NOMESCO Finland

Hospital outpatient

3.3

307.7

1852

3339

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

4132

11093

J01MA02

ATC

ciprofloxacin; systemic

1.9

307.7

13567

48946

Z2221

NOMESCO Finland

Medical doctor

2.0

307.7

10498

35478

ZX120

NOMESCO Finland

Intravenous

3.2

307.7

3509

6788

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

307.7

5205

14104

XCK10

NOMESCO Finland

Photography of fundus of eye

2.7

307.7

2409

5301

SFA10

NOMESCO Finland

One-surface restoration

1.7

307.7

19877

85813

N05CF02

ATC

zolpidem; oral

2.0

307.7

5763

17955

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

307.7

3730

10493

J02AC01

ATC

fluconazole; systemic

1.9

307.7

13674

49352

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

307.7

8017

26796

M03BX02

ATC

tizanidine; oral

1.8

307.7

22558

97531

N06AB03

ATC

fluoxetine; oral

2.2

307.7

4013

11026

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.0

307.7

3094

6260

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

307.7

7033

24231

N17

ICPC

Vertigo/dizziness

2.2

307.7

3810

10403

A02BC01

ATC

omeprazole; systemic

1.9

307.7

9227

32001

H02AB06

ATC

prednisolone; systemic

2.0

307.7

17094

62178

R4110

NOMESCO Finland

Physiotherapy

1.9

307.7

9924

34382

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

26590

121543

L28

ICPC

Limited function/disability (L)

2.4

307.7

5633

14766

P76

ICPC

Depressive disorder

2.6

307.2

2234

5234

L13

ICPC

Hip symptom/complaint

1.9

306.3

5075

16635

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.5

305.9

2337

5611

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

305.6

2335

5606

N03AE01

ATC

clonazepam; systemic

2.9

304.9

1760

3640

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.5

304.7

2418

5913

D07AC01

ATC

betamethasone; topical

1.6

303.5

11526

47463

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

302.5

2235

5277

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.5

301.1

912

1192

M01AC06

ATC

meloxicam; systemic, rectal

1.6

300.5

11083

45304

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.2

299.5

2966

8015

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

298.6

3263

9185

SFA00

NOMESCO Finland

Small restoration

1.9

297.6

4521

14383

K29.7

ICD-10 Finland

Gastritis, unspecified

3.6

297.6

1222

2032

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.9

297.6

1082

1644

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.5

297.0

1232

2063

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.1

296.3

1005

1445

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.1

293.0

3595

10586

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

292.8

4528

14488

H03AA01

ATC

levothyroxine sodium; systemic

1.7

289.7

6785

24660

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

289.5

2647

6905

F29

ICPC

Eye symptom/complaint other

2.2

289.3

3094

8628

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.1

288.9

985

1422

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

288.1

6189

21943

R4190

NOMESCO Finland

Nutritional therapy

3.2

287.2

1411

2646

N76.0

ICD-10 Finland

Acute vaginitis

2.5

286.3

2107

4962

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.0

285.3

984

1434

H53.1

ICD-10 Finland

Subjective visual disturbances

2.5

285.1

2098

4940

R55

ICD-10 Finland

Syncope and collapse

2.1

284.5

3311

9548

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.7

284.2

1112

1785

Z01.7

ICD-10 Finland

Laboratory examination

1.9

282.4

4438

14265

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

281.4

1457

2823

W19

ICD-10 Finland

Unspecified fall

2.1

280.3

3242

9324

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

280.2

11755

49315

R01AD58

ATC

fluticasone, combinations; nasal

1.6

279.8

8087

31052

R35

ICD-10 Finland

Polyuria

2.6

279.1

2019

4712

K07.60

ICD-10 Finland

Snapping jaw

2.8

279.0

1713

3666

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

5.6

278.7

675

711

N05AX12

ATC

aripiprazole; systemic

3.1

278.5

1397

2654

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.3

278.0

2616

6907

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

277.4

7496

28278

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.7

276.8

1789

3937

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.9

276.2

1541

3122

N05BA12

ATC

alprazolam; oral

2.1

275.8

3009

8453

N06AX26

ATC

vortioxetine; oral

2.4

274.7

2390

6093

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.0

274.5

3589

10809

R12

ICD-10 Finland

Heartburn

2.3

273.7

2640

7044

J05AB01

ATC

aciclovir; systemic

1.7

273.4

6740

24801

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

273.2

2373

6045

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

273.1

3365

9911

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

272.8

8786

34624

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

272.8

1572

3245

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

272.7

2662

7139

D07AD01

ATC

clobetasol; topical

1.8

272.1

5097

17321

SDA03

NOMESCO Finland

Periodontal treatment

1.5

271.6

13390

58073

SPAT1254

SPAT

Administration of medicine

1.9

270.2

4383

14225

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

269.7

33437

175592

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

269.5

11434

47996

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.6

268.5

786

996

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

268.1

3920

12281

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.7

268.0

1783

3984

R03AC03

ATC

terbutaline; inhalant

1.9

267.8

4441

14514

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.1

267.8

1372

2640

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.5

267.5

2028

4843

SPAT1301

SPAT

No procedures

1.6

267.4

9480

38193

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

266.9

3256

9551

Z2445

NOMESCO Finland

Psychologist

3.2

266.1

1286

2385

A97

ICPC

No disease

1.7

266.1

5999

21516

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.4

266.0

837

1130

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.8

265.5

1564

3269

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.1

265.0

905

1308

H02AB07

ATC

prednisone; oral

1.9

264.2

4137

13263

L04

ICPC

Chest symptom/complaint

2.5

264.2

1998

4765

XA420

NOMESCO Finland

Extensive sleep examination

9.4

263.1

423

262

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.2

263.1

1242

2269

J01MA14

ATC

moxifloxacin; systemic

2.2

262.6

2709

7432

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

262.4

1258

2321

N30.9

ICD-10 Finland

Cystitis, unspecified

2.5

262.3

2026

4881

C01CA24

ATC

epinephrine; parenteral

2.5

261.1

1942

4593

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

261.0

1963

4668

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.8

261.0

988

1547

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

260.8

3882

12230

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

259.5

2838

7973

A46

ICD-10 Finland

Erysipelas

1.9

259.3

4339

14213

K92.1

ICD-10 Finland

Melaena

2.7

258.5

1703

3784

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

257.0

1534

3229

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

256.7

1993

4813

M01AX17

ATC

nimesulide; oral

1.7

256.6

6813

25519

A05

ICPC

Feeling ill

2.4

254.9

2150

5399

G47.3

ICD-10 Finland

Sleep apnoea

1.7

254.8

6679

24928

S97

ICPC

Chronic ulcer skin

2.6

254.4

1766

4032

H29

ICPC

Ear symptom/complaint other

2.0

253.5

3370

10197

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

253.1

6916

26088

C09CA06

ATC

candesartan; oral

1.6

252.9

7259

27728

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.3

252.9

2295

5957

E000001, ,

ATC

1.7

252.0

6361

23497

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.4

252.0

2081

5174

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.0

251.0

3119

9203

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

250.8

3370

10234

A10AB05

ATC

insulin aspart; parenteral

2.4

250.0

2103

5273

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.1

249.8

2927

8445

J01FA09

ATC

clarithromycin; systemic

1.5

248.3

10051

41603

A10AE04

ATC

insulin glargine; parenteral

2.2

247.8

2612

7224

M01AH01

ATC

celecoxib; oral

1.8

247.6

5146

17999

K29

ICPC

Cardiovascular sympt/complt other

3.1

247.6

1282

2482

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

247.5

9178

37248

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.0

247.1

3201

9590

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

246.6

1546

3343

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

246.3

3612

11309

XG405

NOMESCO Finland

Education on PEF monitoring

7.6

246.1

459

354

R03BA05

ATC

fluticasone; inhalant

1.7

246.1

5624

20207

L04AA06

ATC

mycophenolic acid; systemic

5.0

245.9

660

771

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

245.7

17463

80946

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

245.6

3828

12236

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

244.5

17807

82891

B01AC04

ATC

clopidogrel; oral

1.8

244.5

4272

14171

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.3

244.4

1120

2006

JN4BD

NOMESCO Finland

Extensive body CT

2.0

244.2

3206

9650

Y96.9

ICD-10 Finland

Unspecified type of accident

4.8

244.1

680

823

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.1

243.9

2826

8116

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

242.9

8684

34924

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.1

242.4

832

1207

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.7

242.1

1620

3627

127

Kela drug reimbursment

Transplant complication

6.0

241.7

543

527

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.7

241.0

1505

3247

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

240.9

1945

4783

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

3.1

240.5

1184

2221

R01AD08

ATC

fluticasone; nasal

1.6

240.1

8936

36254

R06AX22

ATC

ebastine; oral

1.7

239.7

5315

18923

R03BA08

ATC

ciclesonide; inhalant

2.2

239.5

2548

7071

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

238.3

5835

21347

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.9

235.2

1327

2703

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.8

234.7

658

801

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.7

234.1

917

1472

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.5

232.9

1787

4287

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.6

232.7

555

575

N06AX22

ATC

agomelatine; oral

4.0

232.7

808

1183

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.6

231.8

1626

3730

P20

ICPC

Memory disturbance

2.0

231.8

3240

9967

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

231.3

4306

14551

N06AX05

ATC

trazodone; oral

3.9

230.7

844

1287

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

229.9

8171

32752

P99

ICPC

Psychological disorders other

3.4

229.7

988

1695

R01AD12

ATC

fluticasone furoate; nasal

1.5

229.5

10273

43307

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

229.4

2217

5908

F34.1

ICD-10 Finland

Dysthymia

3.1

229.2

1133

2130

SPAT1240

SPAT

Therapeutic discussion

1.9

229.1

3269

10126

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

229.0

6325

23854

S80.0

ICD-10 Finland

Contusion of knee

2.2

227.4

2402

6642

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

225.9

1822

4475

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

225.8

8919

36583

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

225.7

8882

36402

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

225.5

3340

10478

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.5

224.9

1763

4272

R07.0

ICD-10 Finland

Pain in throat

2.2

224.7

2365

6529

C10AA05

ATC

atorvastatin; oral

1.5

224.4

11717

50922

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2094

4632

2.71

321.86

1.5

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

1996

4315

2.77

319.97

5.1

4.0

1.28

1.44

mmol/l

7.49

1978

4249

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2496

6065

2.47

319.10

3.7

2.5

0.64

0.65

0.98

2489

6042

(3020682) Albumin/Creatinine [Ratio] in Urine

10381

41408

1.61

314.49

3.9

3.5

11.60

8.58

mg/mmol

5.79

6845

25970

(3007566) Smooth muscle Ab [Titer] in Serum

1771

3618

2.92

313.57

1.4

1.2

102.46

134.59

titre

0.69

122

364

(3034770) Mitochondria Ab [Titer] in Serum

1746

3548

2.93

311.94

1.4

1.2

640.26

1180.51

titre

2.15

(3024980) IgG subclass 4 [Mass/volume] in Serum

1189

1878

3.75

310.81

1.7

1.5

0.70

0.85

g/l

2.82

1029

1291

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1645

3240

3.02

309.66

1.5

1.4

10.32

13.48

iu/ml

0.38

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2932

7776

2.28

309.59

1.1

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1780

3267

3.25

307.65

2.3

2.2

0.03

0.02

g/l

0.53

1657

2988

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5977

19534

1.91

307.65

2.4

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2667

6172

2.61

307.65

2.4

2.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

26284

101647

2.51

307.65

5.4

3.6

1974.00

1206.61

e6/l

0.35

105

2054

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1708

3055

3.34

307.65

2.3

2.2

0.00

g/l

-0.00

1599

2810

(3044889) 12 lead EKG panel

25536

112051

1.92

307.65

4.3

3.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

24670

86770

2.74

307.65

10.9

8.0

4.09

4.16

e9/l

3.48

21998

73807

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1878

3635

3.09

307.65

2.3

2.4

0.56

0.84

g/l

2.71

1701

3120

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

18631

72831

1.92

307.65

2.9

2.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

4138

9806

2.61

307.65

4.1

2.7

4.69

4.57

kpa

2.45

4003

9494

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7408

21721

2.20

307.65

4.1

3.1

0.81

0.82

mmol/l

11.83

7049

20343

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1814

3339

3.25

307.65

2.3

2.1

37.83

37.66

g/l

0.48

1650

2963

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6746

15566

2.82

307.65

3.4

2.4

6.95

9.23

umol/l

12.74

6002

13368

(3023103) Potassium [Moles/volume] in Serum or Plasma

35701

171744

3.31

307.65

21.6

12.1

3.95

3.96

mmol/l

1.25

35064

166016

(3000991) Gas panel - Venous blood

4787

11648

2.57

307.65

9.7

7.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4806

11937

2.51

307.65

5.0

3.3

5.85

5.81

kpa

1.37

4679

11615

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3659

8121

2.77

307.65

4.8

3.4

95.03

87.54

ng/l

3.60

3342

6975

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1958

3905

3.00

307.65

2.3

2.1

10.10

10.36

g/l

1.55

1787

3512

(3000330) Specific gravity of Urine by Test strip

2896

6012

2.93

307.65

3.2

2.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5521

14324

2.43

307.65

4.7

3.9

238.66

246.40

u/l

2.12

5253

13620

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6436

22032

1.83

307.65

2.5

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

22794

86313

2.26

307.65

6.1

4.1

6.64

6.62

mmol/l

0.66

21550

79247

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

32833

161673

2.08

307.65

4.8

3.8

5.93

5.81

mmol/l

47.70

30820

147961

(3020961) Endomysium IgA Ab [Titer] in Serum

2810

7114

2.38

307.65

1.2

1.1

132.72

252.04

titre

1.68

213

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5348

9994

3.43

307.65

3.3

2.2

63.87

69.35

ml/min/173m2

12.47

1835

3985

(46235355) HIV 1 and 2 tests - Meaningful Use set

9401

34517

1.76

307.65

2.2

1.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

8112

20244

2.66

307.65

3.0

2.1

12.80

13.56

umol/l

12.78

7709

18775

(3019550) Sodium [Moles/volume] in Serum or Plasma

35642

171030

3.30

307.65

21.5

12.0

139.53

139.68

mmol/l

23.11

35077

165710

(3015377) Calcium [Moles/volume] in Serum or Plasma

13320

47364

1.95

307.65

3.4

3.5

2.35

mmol/l

2.16

11824

42473

(3027945) Reticulocytes/100 erythrocytes in Blood

5479

14012

2.47

307.65

2.7

2.4

1.84

1.70

15.69

4970

12453

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3090

8002

2.34

307.65

1.3

1.2

49.12

52.27

au/ml

0.26

127

476

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4539

12231

2.30

307.65

8.9

8.0

119.85

122.74

g/l

14.79

4502

11862

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4101

8573

2.97

307.65

1.8

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8017

25496

2.03

307.65

2.9

3.2

2.44

2.45

mmol/l

11.57

7060

22129

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

32998

169574

1.80

307.65

4.6

3.7

4.57

4.74

mmol/l

167.13

31283

158664

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

14735

51408

2.06

307.65

4.1

3.0

38.50

61.33

ng/l

3.84

9850

32033

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10115

24143

2.92

307.65

3.1

2.5

0.96

1.34

e6/l

2.11

6551

11900

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1945

4021

2.89

307.65

1.6

312.73

296.48

titre

0.06

172

(3005322) IgE [Units/volume] in Serum or Plasma

3291

7918

2.53

307.65

1.4

1.2

217.62

257.84

u/ml

0.95

3069

7309

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7501

18663

2.64

307.65

3.0

2.1

2.36

2.34

g/l

1.86

7102

17088

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

33421

158465

2.51

307.65

16.0

10.4

85.16

84.73

ml/min/173m2

2.62

28149

126392

(3003396) Base excess in Arterial blood by calculation

5472

14620

2.35

307.65

8.1

7.2

0.95

0.91

mmol/l

0.34

4431

11742

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6245

16332

2.44

307.65

7.4

4.8

1.05

1.03

mmol/l

4.02

5898

15199

(40768804) Tissue Pathology biopsy report

16574

61586

1.97

307.65

2.2

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3151

7749

2.47

307.65

2.5

2.2

—

(3002032) Base excess in Venous blood by calculation

4809

11878

2.53

307.65

5.0

3.3

1.76

1.79

mmol/l

0.17

4144

10161

(3000850) Epithelial cells [#/volume] in Urine

9706

30524

2.12

307.65

2.9

2.3

5.31

6.05

e6/l

4.58

8795

26826

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5907

14358

2.63

307.65

1.9

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1887

3017

3.75

307.65

1.4

273.13

268.46

ug/g

0.36

1118

1741

(3000494) Fungus identified in Specimen by Culture

5331

15758

2.11

307.65

1.6

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7063

22575

1.99

307.65

1.3

1.2

12.52

11.55

u/ml

0.24

2388

9222

(3009261) Glucose [Presence] in Urine by Test strip

19842

80269

1.87

307.65

4.5

3.0

0.01

0.00

estimate

0.12

1771

15718

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1974

3868

3.06

307.65

2.3

2.1

3.05

3.03

g/l

0.36

1814

3495

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5834

14204

2.62

307.65

1.9

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

25501

120989

1.63

307.65

3.6

3.0

—

(3026008) Bacteria identified in Urine by Culture

12070

41575

1.98

307.65

3.4

2.6

—

(4200892) Spirometry reversibility

3370

9016

2.27

307.65

1.5

1.4

—

(3023368) Bacteria identified in Blood by Culture

11510

37309

2.11

307.65

5.0

4.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

13893

33744

3.14

307.65

4.5

2.9

—

(3020891) Body temperature

2387

5255

2.73

307.65

5.8

4.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2567

6172

2.50

307.65

3.8

2.5

1.36

1.29

2.18

2558

6139

(3007853) Bacteria identified in Skin by Aerobe culture

6188

15591

2.54

307.65

2.0

1.6

—

(40761535) Cells panel - Urine sediment

5824

9049

4.20

307.65

4.2

2.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7063

17397

2.65

307.65

3.1

2.2

21.77

23.48

16.39

6490

14874

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

28702

123420

2.29

307.65

4.5

3.5

14.68

14.66

pmol/l

0.58

26832

111668

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7356

20555

2.32

307.65

2.7

1.9

30.01

29.94

0.35

7203

19967

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

33500

172579

1.85

307.65

5.1

4.1

2.72

2.84

mmol/l

114.51

31643

160305

(3026361) Erythrocytes [#/volume] in Blood

37648

200031

3.33

307.65

28.9

15.1

4.46

4.56

e12/l

275.35

36975

192653

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3461

6558

3.25

307.65

1.8

1.5

—

(3006504) Eosinophils/100 leukocytes in Blood

19417

69526

2.22

307.65

7.6

5.2

2.87

2.82

2.37

18392

64970

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4921

8922

3.51

307.65

2.8

2.0

6.61

8.61

ug/l

5.86

4338

7826

(42529406) Shigella sp [Presence] in Stool by Culture

2314

3815

3.67

307.65

1.3

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

22321

73477

2.76

307.65

6.9

5.6

11.06

11.94

umol/l

17.24

21394

69350

(3007164) IgA [Mass/volume] in Serum or Plasma

10239

27587

2.55

307.65

1.6

1.4

2.36

2.39

g/l

0.65

5865

17473

(3033658) Prothrombin time (PT) actual/Normal

12582

39166

2.26

307.65

5.5

3.4

90.28

90.37

0.13

12276

38238

(40761511) CBC panel - Blood by Automated count

36258

182837

3.00

307.65

16.2

10.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

19897

73180

2.17

307.65

7.7

5.2

28.23

28.22

0.01

18897

68732

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2282

3786

3.64

307.65

1.3

1.1

—

(40758558) Short blood count panel - Blood

14599

35829

3.16

307.65

8.2

6.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1719

3091

3.32

307.65

2.3

2.2

0.00

g/l

0.18

1601

2818

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11218

33719

2.30

307.65

3.4

2.7

1416.28

1432.02

ng/l

0.11

9717

28529

(3012516) Albumin [Mass/volume] in Urine

10028

39187

1.65

307.65

3.5

3.0

338.51

327.62

mg/l

0.09

6801

24826

(3014051) Protein [Presence] in Urine by Test strip

2481

2564

5.91

307.65

2.6

2.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

37650

200127

3.32

307.65

29.1

15.2

133.64

137.11

g/l

307.65

37363

196940

(3001122) Ferritin [Mass/volume] in Serum or Plasma

19007

68058

2.20

307.65

3.7

2.5

113.16

121.21

ug/l

3.28

17950

63249

(3019069) Monocytes/100 leukocytes in Blood

19521

70015

2.22

307.65

7.9

5.4

8.47

8.54

2.29

18515

65506

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7050

14215

3.28

307.65

9.8

5.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

31001

150303

1.93

307.65

6.1

4.6

39.50

38.72

mmol/mol

32.48

29321

139375

(3004716) Salmonella sp identified in Stool by Organism specific culture

3206

8368

2.32

307.65

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6587

18621

2.26

307.65

1.9

1.5

—

(3045414) Leukocytes [Presence] in Urine

3382

4849

4.32

307.65

2.2

1.5

—

(3006315) Basophils [#/volume] in Blood

22198

73364

2.73

307.65

7.6

5.0

0.04

e9/l

1.29

19664

61805

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3391

8785

2.35

307.65

2.4

2.3

22.95

22.48

au/ml

0.09

248

826

(36304419) Bacteria [Presence] in Urine

13277

40819

2.33

307.65

3.7

2.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3897

9596

2.50

307.65

2.6

2.3

66.34

66.52

g/l

0.66

3583

8806

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11304

31934

2.47

307.65

1.4

1.2

2.17

1.74

u/ml

1.60

2674

9205

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3085

6382

2.95

307.65

5.4

3.6

24.11

24.13

mmol/l

0.16

3034

6253

(3007461) Platelets [#/volume] in Blood

37630

199723

3.33

307.65

28.9

15.1

253.84

252.01

e9/l

5.70

37045

193018

(3042936) Bacteria identified in Isolate by Culture

6741

19050

2.26

307.65

2.4

1.8

—

(3021589) Normoblasts [#/volume] in Blood

17261

72106

1.69

307.65

9.7

8.7

0.01

0.00

e9/l

0.92

14162

57411

(3024731) MCV [Entitic volume]

37645

199997

3.33

307.65

28.8

15.1

90.79

90.49

28.05

37345

196746

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10781

34528

2.11

307.65

2.7

2.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

18174

63731

2.21

307.65

16.5

12.5

1.25

1.23

inr

1.14

3850

20348

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2055

4076

3.02

307.65

2.3

2.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

28546

113166

2.70

307.65

4.8

3.2

12.01

11.21

mm/h

16.12

27031

104338

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14623

50023

2.10

307.65

3.9

2.7

34.40

34.13

u/l

0.08

14065

47226

(3015736) pH of Urine

16841

64319

1.90

307.65

4.4

2.7

5.93

5.86

2.09

1083

5879

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2857

6930

2.49

307.65

10.2

9.8

24.27

24.35

mmol/l

0.62

2774

6707

(3014765) Yersinia sp identified in Stool by Organism specific culture

2312

3808

3.67

307.65

1.3

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12107

32857

2.64

307.65

2.8

2.0

3.01

2.89

mg/l

5.18

10584

27797

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20538

66396

2.66

307.65

8.2

5.4

1.21

mmol/l

9.86

18948

53684

(40768797) Stomach Pathology biopsy report

8425

16283

3.54

307.65

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7543

24220

1.99

307.65

1.3

1.2

36.87

37.02

iu/ml

0.01

2290

7974

(3035350) Ketones [Presence] in Urine by Test strip

19629

79232

1.87

307.65

4.5

3.0

0.00

estimate

0.08

1897

16826

(3002385) Erythrocyte distribution width [Ratio]

30765

153477

1.75

307.65

22.5

12.8

14.80

14.78

0.07

30504

149816

(3020779) Urea [Moles/volume] in Serum or Plasma

4373

10978

2.47

307.65

9.7

5.8

9.41

9.58

mmol/l

0.77

4191

10425

(3018010) Neutrophils/100 leukocytes in Blood

19728

71689

2.19

307.65

7.5

5.0

56.93

57.12

1.28

18754

67249

(36660697) Celiac disease serology panel - Serum

4368

11069

2.44

307.65

1.2

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

18067

60416

2.36

307.65

5.8

4.3

35.86

35.64

g/l

5.17

17160

55826

(3022621) pH of Urine by Test strip

3413

9010

2.31

307.65

2.8

2.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

19702

79427

1.88

307.65

5.8

4.0

0.00

estimate

0.57

1817

16194

(3001604) Monocytes [#/volume] in Blood

22165

73240

2.73

307.65

7.6

5.0

0.56

0.59

e9/l

27.59

19625

61761

(3027801) Oxygen [Partial pressure] in Arterial blood

5398

14456

2.35

307.65

8.1

7.3

12.65

12.66

kpa

0.06

5248

13742

(3028026) IgM [Mass/volume] in Serum or Plasma

3200

7332

2.66

307.65

1.8

1.9

1.29

g/l

0.01

2972

6692

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8644

22650

2.55

307.65

3.3

2.6

2.71

2.82

e6/l

0.30

5131

10457

(3023520) Reticulocytes [#/volume] in Blood

4105

9668

2.63

307.65

2.6

2.5

72.75

68.64

e9/l

7.71

3043

6842

(3030467) Casts [#/volume] in Urine by Automated count

13444

41329

2.34

307.65

3.9

2.7

0.34

0.47

e6/l

8.27

10776

29414

(3048689) Calprotectin [Mass/mass] in Stool

7524

16778

2.97

307.65

2.6

2.5

125.71

139.46

ug/g

2.27

6158

13403

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13976

42267

2.42

307.65

3.0

2.3

59.43

65.66

u/l

1.30

13139

38862

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2461

5591

2.65

307.65

1.1

9.01

4.08

u/ml

0.55

(3014111) Lactate [Moles/volume] in Serum or Plasma

5408

11503

3.00

307.65

7.4

7.1

1.33

1.35

mmol/l

0.95

5308

11213

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4710

12187

2.40

307.65

2.9

2.0

0.22

g/l

0.89

4420

11316

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

29670

116696

2.95

307.65

9.3

6.4

77.84

77.90

u/l

0.07

28473

109190

(3020564) Creatinine [Moles/volume] in Serum or Plasma

36399

184144

3.05

307.65

21.5

12.1

77.50

76.01

umol/l

10.25

36390

184045

(3019309) Folate [Moles/volume] in Red Blood Cells

7502

22371

2.16

307.65

1.7

1200.43

1208.51

nmol/l

0.27

6009

16763

(3019150) Specific gravity of Urine by Refractometry

10551

32136

2.23

307.65

5.2

3.2

1.02

kg/l

0.63

917

4794

(3013139) Helicobacter pylori Ag [Presence] in Stool

3717

8796

2.60

307.65

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2669

5164

3.14

307.65

1.8

1.6

1.47

1.52

g/l

1.69

2311

4358

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3652

8417

2.67

307.65

9.8

9.1

1.44

1.34

4.89

3631

8368

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17761

53267

2.70

307.65

2.2

1.7

94.42

95.07

pmol/l

0.95

9757

27482

(3043409) Potassium [Moles/volume] in Arterial blood

1879

3706

3.03

307.65

5.3

4.2

3.87

3.90

mmol/l

1.61

1866

3678

(3009542) Hematocrit [Volume Fraction] of Blood

37611

199532

3.32

307.65

29.2

15.2

40.01

40.97

18.63

36763

186705

(3009508) Creatinine [Moles/volume] in Urine

11634

43103

1.80

307.65

3.7

2.9

7.66

8.10

mmol/l

14.61

10206

36562

(3012544) pH of Venous blood

4849

12382

2.44

307.65

4.9

3.3

7.38

0.18

117

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8034

28537

1.79

307.65

1.9

1.6

—

(3035941) MCH [Entitic mass]

37638

199975

3.32

307.65

28.7

15.0

30.22

0.32

37341

196729

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

32866

151943

2.57

307.65

5.4

3.9

1.84

2.18

mu/l

8.07

31021

139265

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6244

12936

3.13

307.65

3.1

2.3

52.99

43.66

u/l

0.36

5375

11147

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4422

12312

2.21

307.65

1.6

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3648

8419

2.66

307.65

9.9

9.2

0.68

0.66

1.78

3631

8376

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2053

4072

3.02

307.65

2.3

2.1

3.75

3.85

g/l

1.86

1893

3698

(3028707) Methadone [Presence] in Urine by Screen method

1495

2053

4.34

307.65

4.2

2.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

35787

170956

3.46

307.65

19.6

10.5

23.10

24.79

mg/l

16.58

29606

129590

(3044640) Blood type and Crossmatch panel - Blood

13332

47565

1.94

307.65

2.8

2.1

—

(3013115) Eosinophils [#/volume] in Blood

22709

75963

2.74

307.65

7.9

5.2

0.19

e9/l

0.42

20381

65456

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

31854

161433

1.76

307.65

4.1

3.4

1.31

1.28

mmol/l

6.91

29896

149291

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

24597

114858

1.64

307.65

3.8

2.5

50.14

44.92

u/l

12.93

23386

108060

(3010813) Leukocytes [#/volume] in Blood

37652

200038

3.34

307.65

28.9

15.1

6.84

6.69

e9/l

14.90

36987

192618

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4344

11112

2.42

307.65

2.3

2.2

369.72

382.46

nmol/l

3.56

3983

10347

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3634

6798

3.31

307.65

1.6

1.4

—

(3022096) Basophils/100 leukocytes in Blood

18842

67279

2.20

307.65

7.6

5.2

0.70

0.66

14.10

17787

62654

(3021960) Folate [Moles/volume] in Serum or Plasma

10145

29306

2.35

307.65

1.7

1.4

20.35

19.92

nmol/l

1.95

9069

25240

(3022145) Colonoscopy Study observation

5875

15129

2.47

307.65

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

36409

185633

2.93

307.65

13.3

8.0

26.63

27.02

u/l

2.20

35645

178673

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

32706

168306

1.76

307.65

4.5

3.7

1.43

1.45

mmol/l

13.29

30869

156646

(3018418) pH of Serum or Plasma

13676

42331

2.34

307.65

5.2

3.6

7.40

1.01

1128

9734

(40760892) CBC W Ordered Manual Differential panel - Blood

20359

69466

2.45

307.65

7.5

5.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2054

3953

3.12

307.65

2.6

2.2

401.13

633.43

ug/l

1.87

1944

3716

(3018095) Leukocytes [#/volume] in Urine

15711

53538

2.17

307.65

4.5

3.1

73.03

97.54

e6/l

3.42

11696

35329

(3037522) Nuclear Ab [Titer] in Serum

6798

18444

2.37

307.65

1.5

1.3

517.10

532.33

titre

0.23

1340

3322

(3037467) Urinalysis macro (dipstick) panel - Urine

26100

108508

2.17

307.65

5.0

3.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

10670

39165

1.79

307.65

2.9

2.3

2511.65

5166.79

umol/l

12.24

9461

34636

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

16910

57269

2.25

307.65

2.6

2.0

75.02

75.53

nmol/l

1.37

15526

51852

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5400

14467

2.34

307.65

8.1

7.3

5.08

kpa

0.08

5248

13757

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6055

20614

1.83

307.65

2.1

1.6

1.52

1.37

37.53

5398

18322

(3003338) MCHC [Mass/volume]

32273

156673

2.09

307.65

26.7

12.9

331.88

333.21

g/l

114.61

32100

155238

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2055

4079

3.02

307.65

2.3

2.1

7.27

7.41

g/l

2.70

1892

3704

(3016502) Oxygen saturation in Arterial blood

4927

12842

2.39

307.65

8.6

7.7

95.73

95.66

0.29

4824

12325

(3014007) Fractional oxyhemoglobin in Arterial blood

3679

8477

2.67

307.65

9.9

9.3

93.90

93.80

0.41

3670

8446

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1621

2918

3.31

307.65

1.4

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10462

30538

2.34

307.65

2.2

1.6

1.15

1.25

mg/l

1.52

7967

23326

(3002582) Erythrocytes [#/volume] in Urine

13599

45294

2.13

307.65

3.9

2.7

58.37

111.07

e6/l

5.42

10826

32726

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

19466

61248

2.67

307.65

7.6

5.3

1.21

mmol/l

1.47

18345

55957

(3003327) Ova and parasites identified in Stool by Light microscopy

2320

4461

3.13

307.65

1.8

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8758

25234

2.30

307.65

4.1

3.1

370.46

603.35

ng/l

5.53

6648

19003

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2394

5262

2.74

307.65

1.5

12.07

13.17

u/ml

0.15

137

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

13160

38387

2.48

307.65

2.5

1.9

210.75

226.43

u/l

0.54

12522

35808

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7403

20207

2.38

307.65

2.0

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3959

9316

2.62

307.65

2.8

2.4

10.51

10.79

g/l

3.26

3734

8406

(3019198) Lymphocytes [#/volume] in Blood

22587

76492

2.67

307.65

7.6

5.0

1.93

1.94

e9/l

0.21

20412

66492

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2011

4487

2.68

303.77

2.1

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1798

3773

2.84

303.69

1.7

1.5

1.18

g/l

0.57

1716

3617

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1823

3873

2.81

301.20

4.9

3.2

24.56

24.83

mmol/l

3.39

1711

3597

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1753

3651

2.86

299.96

1.8

1.5

0.23

0.24

g/l

3.07

1667

3486

(1761868) Lipid panel - Serum or Plasma

8808

72028

0.62

298.17

2.4

2.6

—

(3025941) Bacteria identified in Stool by Culture

3074

8543

2.17

289.88

1.4

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4281

13543

1.93

285.74

3.7

4.4

16.80

33.26

ug/l

2.40

3424

10802

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2079

4879

2.55

284.39

1.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2203

5424

2.43

272.88

4.1

3.4

53.09

48.17

15.35

2183

5367

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2184

5390

2.42

269.08

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

905

1304

4.09

265.99

1.6

—

(3019060) Gas panel - Arterial blood

2883

8093

2.15

264.31

5.1

4.4

—

(3036489) Thrombin time

2167

5376

2.41

263.92

2.7

1.9

21.52

21.35

0.56

1935

4668

(3019225) pH of Specimen

3315

9834

2.04

263.58

4.6

3.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1297

2450

3.13

260.71

1.6

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2058

5032

2.44

258.33

1.3

1.2

0.68

0.64

u/ml

0.07

195

497

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8465

33466

1.59

256.96

1.8

1.5

—

(3011288) Drugs identified in Urine by Screen method

1875

4397

2.54

256.31

5.3

2.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1281

2441

3.10

253.86

1.6

1.4

—

(3026782) Osmolality of Urine

7745

30044

1.61

253.76

3.2

2.5

542.08

555.40

mosm/kgh2o

5.32

6628

25523

(3052851) Hemolysis interference index of Serum or Plasma

1820

4286

2.53

246.53

3.5

2.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2463

6679

2.21

245.00

4.5

3.0

1.46

1.95

mmol/l

7.67

1789

4848

(3009343) pH of Capillary blood

2504

6853

2.19

243.60

4.5

3.0

7.41

7.42

0.66

216

1429

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2519

6913

2.18

243.43

4.5

3.0

5.13

5.15

kpa

0.32

2376

6570

(3004119) Hemoglobin [Mass/volume] in Venous blood

2765

7924

2.10

239.75

4.0

2.8

126.38

131.03

g/l

18.66

2732

7736

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2721

7762

2.10

238.70

8.5

6.5

24.58

24.46

mmol/l

0.94

2660

7328

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2015

5083

2.36

236.14

2.0

1.9

39.62

39.18

u/l

0.36

1806

4517

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1600

3607

2.63

235.94

1.6

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1493

3251

2.72

234.99

1.2

42.06

36.99

u/ml

0.21

213

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1252

2473

2.99

233.77

7.4

3.7

1302.20

3962.43

iu/ml

0.49

192

258

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1917

4759

2.40

232.48

3.6

662.51

2923.01

u/ml

1.05

1639

4105

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2880

8542

2.03

227.72

3.2

3.5

4.45

4.55

pmol/l

4.82

2557

7717

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1728

4129

2.49

226.92

3.4

2.2

184.52

187.68

0.71

1642

3917

(3029937) Albumin [Presence] in Urine by Test strip

10215

43309

1.49

220.25

5.4

3.2

0.00

estimate

0.23

1745

15360

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1741

4255

2.43

218.01

3.7

2.9

0.32

0.35

u/ml

2.67

996

2313

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1714

4158

2.45

218.00

1.4

1.6

1.46

2.28

iu/ml

0.19

425

876

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3069

9535

1.94

212.58

2.1

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

970

1733

3.29

212.23

1.4

1.3

21.78

25.67

u/l

2.68

778

1475

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1732

4278

2.40

211.97

3.5

2.3

3.49

3.70

g/l

5.71

1661

4079

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3750

12460

1.82

211.65

2.3

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1818

4629

2.33

208.19

3.0

2.0

92.08

91.88

0.12

1768

4432

(3022313) Gas panel - Capillary blood

1795

4552

2.34

207.39

5.0

3.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1424

3238

2.60

206.15

2.1

2.0

12.74

10.25

mg/l

16.33

1334

3065

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1114

2233

2.94

202.68

1.2

0.88

16.19

u/ml

1.70

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1520

3619

2.49

200.69

1.3

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1952

5224

2.22

199.29

1.4

1.3

226.71

229.78

miu/ml

0.12

798

2534

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1086

2166

2.95

199.24

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1254

2715

2.73

199.09

1.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2028

5535

2.18

197.51

3.6

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1335

3007

2.62

196.73

1.2

13.76

9.90

u/ml

0.63

155

416

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1243

2702

2.72

195.86

1.6

1.3

17.13

23.15

u/ml

0.61

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1122

2312

2.86

194.60

1.2

5.36

7.31

u/ml

0.18

177

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1211

2623

2.72

192.05

1.2

36.82

47.13

u/ml

0.94

100

264

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1194

2568

2.74

191.82

1.3

1.2

271.65

252.52

u/ml

1.27

831

1668

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1307

2966

2.60

189.77

1.2

5.62

10.95

u/ml

1.03

105

274

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

954

1816

3.09

188.96

3.7

2.1

624.80

4136.05

u/ml

2.19

(3023511) Choriogonadotropin [Units/volume] in Urine

1354

3137

2.55

188.74

1.5

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1235

2735

2.66

187.88

1.6

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6641

26456

1.54

186.78

1.5

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3079

10008

1.85

185.09

2.8

2.5

232.06

208.14

ng/l

1.45

2752

9055

(3036180) Methadone [Presence] in Urine

469

522

5.25

183.51

3.6

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

13725

63124

1.40

183.44

4.9

3.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1172

2557

2.70

183.31

1.6

1.3

103.35

104.53

u/ml

0.15

202

614

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

688

1070

3.77

183.14

1.3

1.2

175.77

153.64

titre

0.10

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

689

1073

3.76

183.07

1.3

1.2

200.00

198.75

titre

0.01

118

168

(3017732) Neutrophils [#/volume] in Blood

2877

9188

1.88

182.51

2.9

2.5

6.31

4.85

e9/l

3.12

2291

7820

(3023183) Ammonium ion [Moles/volume] in Plasma

1149

2508

2.70

179.53

3.4

2.4

33.74

35.16

umol/l

0.97

1051

2256

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

640

959

3.91

178.84

1.7

1.5

—

(3024928) Oxygen saturation in Venous blood

1210

2726

2.62

178.06

4.1

2.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2238

6620

2.01

176.80

2.5

2.1

5617.10

6755.90

u/l

0.71

751

2703

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

848

1568

3.18

175.84

1.8

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

848

1569

3.17

175.66

1.8

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1829

5016

2.16

175.61

1.3

1.2

—

(3013512) EKG study

8878

38023

1.45

174.26

3.9

3.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3915

13908

1.70

173.83

4.2

3.8

31.88

31.70

0.42

2756

9615

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1448

3608

2.37

173.38

3.3

3.1

39.14

43.90

mg/l

0.51

1329

2600

(3034860) Kappa light chains.free [Mass/volume] in Serum

1450

3621

2.37

172.77

3.3

3.1

52.14

64.06

mg/l

0.57

1330

2613

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

505

642

4.60

171.79

2.6

2.2

743.00

651.66

e6/l

1.64

495

613

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1049

2238

2.76

170.87

1.7

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

591

869

3.98

169.17

1.7

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

2456

7629

1.92

168.79

3.3

1.6

—

(40761536) Microorganisms panel - Urine sediment

1558

17958

0.48

167.55

4.9

3.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1402

3496

2.37

167.52

3.3

3.1

1.99

4.62

ratio

0.53

199

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1242

2924

2.50

167.44

1.4

1.3

467.73

566.69

mg/l

3.01

1201

2799

(3028300) Cannabinoids [Presence] in Urine

2469

7722

1.91

166.22

3.4

1.6

—

(3027008) Opiates [Presence] in Urine

2456

7699

1.90

164.15

3.1

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

693

1179

3.44

162.86

1.5

1.3

6.33

7.01

g/l

3.50

581

689

(3024139) IgG subclass 3 [Mass/volume] in Serum

692

1177

3.44

162.68

1.5

1.3

0.40

0.42

g/l

0.56

582

686

(3028192) IgG subclass 2 [Mass/volume] in Serum

692

1177

3.44

162.68

1.5

1.3

2.96

3.03

g/l

0.42

580

690

(3026250) Tacrolimus [Mass/volume] in Blood

359

343

6.10

162.05

40.2

31.8

7.18

7.48

ug/l

1.18

329

315

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1125

2563

2.58

161.87

1.3

1.2

3.72

3.70

mmol/l

0.29

1072

2415

(3019420) Tryptase [Mass/volume] in Serum or Plasma

408

451

5.28

160.76

1.4

1.6

7.95

7.25

ug/l

0.25

381

398

(3016879) Cocaine [Presence] in Urine

2276

7054

1.92

157.11

3.4

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

921

1917

2.82

156.74

1.6

—

(4062490) Immunoglobulin typing, IgG

681

1177

3.39

156.39

1.5

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

613

991

3.62

154.82

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

613

991

3.62

154.82

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1673

4653

2.13

154.79

2.1

1.8

2.58

2.50

ug/l

0.07

1508

4155

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

612

990

3.62

154.43

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

744

1379

3.16

153.64

6.3

5.4

11.24

11.22

mg/l

0.04

680

1256

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

608

983

3.62

153.53

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

606

981

3.61

152.76

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

606

982

3.61

152.55

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2875

9720

1.77

150.80

8.6

6.4

24.87

24.72

mmol/l

1.31

2862

9620

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

983

2180

2.65

148.89

1.4

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1440

3845

2.21

147.06

2.7

2.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

370

411

5.25

145.11

2.1

1.5

1.96

umol/l

0.01

342

385

(3000475) Leukocytes [#/volume] in Synovial fluid

1195

2962

2.38

144.44

1.7

1.6

13200.13

13753.92

e6/l

0.14

857

2090

(40757494) Bilirubin.total [Moles/volume] in Blood

433

561

4.50

144.22

2.2

2.0

30.44

52.05

umol/l

1.08

(3010375) cycloSPORINE [Mass/volume] in Blood

359

390

5.36

143.92

30.2

24.0

114.17

126.99

ug/l

1.43

293

342

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

646

1144

3.30

143.08

1.7

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

646

1146

3.30

142.70

1.7

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

966

2171

2.61

142.61

1.3

1.2

4.09

3.95

u/ml

0.12

437

991

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

583

967

3.53

142.06

1.1

51.29

82.20

u/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1961

5985

1.94

141.16

3.9

2.9

24.89

25.26

mmol/l

4.86

1915

5787

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

495

737

3.92

139.47

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

495

737

3.92

139.47

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

495

737

3.92

139.47

1.7

1.5

—

(3042733) HLA Ab [Presence] in Serum

310

303

5.96

137.19

4.9

5.2

—

(3027944) Amphetamines [Presence] in Urine

2347

7674

1.82

136.96

3.1

1.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

428

578

4.32

135.92

2.4

2.8

1059.05

1058.39

u/ml

0.00

419

572

(3016650) Hepatitis A virus Ab [Presence] in Serum

1002

2353

2.50

135.58

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1344

3608

2.20

135.37

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

763

1551

2.88

135.28

1.2

52.08

49.27

u/ml

0.08

104

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

563

966

3.41

130.68

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1082

2701

2.35

128.67

1.5

1.4

1444.28

970.47

e6/l

0.33

881

2112

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1404

3933

2.10

127.21

1.4

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1076

2699

2.34

126.60

1.4

27.64

32.19

e6/l

0.14

856

1981

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

427

613

4.06

125.99

3.0

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1189

3127

2.24

125.64

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1189

3129

2.24

125.45

1.4

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

453

685

3.86

125.14

1.2

21.25

24.21

u/l

0.64

410

587

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

459

705

3.80

124.23

1.2

90.43

86.24

u/l

0.35

422

612

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

457

703

3.79

123.44

2.6

1.7

95.06

97.82

0.76

436

655

(3029634) Reagin Ab [Titer] in Serum by VDRL

748

1587

2.76

122.93

2.4

1.7

13.45

3.29

titre

1.32

(3019832) Treponema pallidum Ab [Presence] in Serum

4837

19549

1.49

121.86

1.9

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

781

1705

2.68

121.78

5.2

4.6

361.29

362.86

umol/l

0.10

703

1454

(21494890) Protein electrophoresis panel - 24 hour Urine

608

1152

3.09

121.22

2.1

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

732

1555

2.76

120.02

1.6

1.5

29.78

30.58

iu/ml

0.03

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

405

581

4.06

119.62

2.6

2.2

0.23

e9/l

0.18

336

481

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

638

1255

2.97

119.61

3.4

6.05

9.49

nmol/l

0.36

625

1224

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

416

610

3.98

119.55

2.6

2.1

537.20

509.62

e6/l

0.44

338

481

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

491

819

3.50

118.72

1.6

1.3

—

(3000492) Spirometry study

4188

16527

1.52

117.86

1.5

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2170

7247

1.78

117.65

11.7

9.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

579

1085

3.12

117.50

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

336

417

4.69

117.46

2.9

2.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

768

1695

2.65

117.31

1.1

1.50

1.51

g/l

0.31

712

1548

(3016244) Insulin [Units/volume] in Serum or Plasma

447

705

3.70

116.80

2.9

3.0

27.75

28.08

mu/l

0.04

409

675

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

191

123

9.02

116.05

2.6

2.9

0.60

0.52

u/field

0.37

191

123

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2945

10773

1.63

114.51

1.2

133.02

150.23

iu/ml

1.35

997

4268

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

489

837

3.41

113.93

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

797

1821

2.56

113.85

1.3

1.2

—

(21494434) Karyotype in Bone marrow

495

861

3.36

112.64

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

407

621

3.82

111.16

11.8

11.6

0.61

0.62

mmol/l

0.26

385

562

(3020191) Ethanol [Moles/volume] in Serum or Plasma

543

1020

3.11

109.79

1.7

1.4

1.62

1.37

promille

2.85

436

756

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

684

1471

2.72

109.66

2.5

2.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

925

2318

2.34

108.99

1.3

1.2

3.21

3.91

u/ml

0.54

313

817

(3000034) Microalbumin [Mass/volume] in Urine

507

920

3.22

108.23

2.8

44.48

45.72

mg/l

0.04

356

637

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

411

646

3.71

107.92

3.3

3.7

100.04

128.78

nmol/l

0.93

405

637

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

372

543

3.99

107.56

3.3

2.7

42739.35

42157.93

ug/l

0.20

372

543

(40760888) Immunoglobulin light chains.free panel - Serum

1021

2695

2.22

106.86

3.5

3.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

901

2254

2.34

106.55

1.6

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

646

1375

2.75

105.55

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

338

465

4.23

105.09

2.9

1.6

139.93

110.64

umol/l

0.87

189

222

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

622

1300

2.80

105.03

1.9

1.5

7486.90

5351.11

titre

0.20

(3025468) Yersinia sp identified in Specimen by Organism specific culture

539

1040

3.03

104.36

1.5

1.3

—

(3037121) Protein [Mass/volume] in Urine

1289

3773

2.01

103.81

3.1

3.5

0.30

0.31

g/l

0.03

698

1901

(40768443) Skin Pathology biopsy report

1843

6081

1.79

103.71

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

538

1042

3.01

103.52

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

537

1040

3.01

103.34

1.5

1.3

—

(3037756) Immunofixation for Serum or Plasma

898

2284

2.30

102.35

1.5

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

710

1620

2.56

101.69

1.3

0.59

2.36

nmol/l

1.11

688

1550

(3009214) Lutropin [Units/volume] in Serum or Plasma

1515

4738

1.88

100.90

1.4

1.3

9.79

8.90

u/l

1.53

1213

3854

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

533

1043

2.98

100.83

1.5

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

354

526

3.92

100.10

3.0

2.4

38.10

38.50

0.11

196

263

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

665

1482

2.62

99.71

2.5

2.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

702

1611

2.55

99.41

1.3

0.18

0.25

nmol/l

0.69

107

(3049717) Cytology report of Urine Cyto stain

1510

4744

1.87

99.16

2.4

2.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

534

1060

2.94

98.63

1.5

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

661

1478

2.61

98.48

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

541

1091

2.89

97.27

1.5

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

807

2013

2.35

96.03

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

599

1290

2.71

95.80

1.2

60.96

68.85

u/l

1.02

558

1140

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

873

2268

2.25

94.79

1.1

—

(3008898) HLA-B27 [Presence]

1637

5366

1.80

93.96

1.1

—

(3003181) Sodium [Moles/volume] in Urine

777

1938

2.35

92.48

1.6

1.4

63.78

62.92

mmol/l

0.19

619

1507

(3010838) Calcium [Moles/time] in 24 hour Urine

807

2049

2.31

92.32

1.8

1.9

4.86

5.39

mmol/24h

4.02

707

1858

(3000060) B lymphocytes [#/volume] in Blood

241

275

5.09

92.14

2.6

1.7

201.43

1558.89

e6/l

0.81

168

135

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1185

3531

1.97

90.75

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

538

1126

2.79

90.65

3.9

3.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

458

873

3.06

90.51

1.1

295.98

286.35

mg/l

1.39

427

792

(3002256) Pathology report gross observation

4880

20807

1.41

90.44

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

309

447

4.02

90.43

1.1

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

371

616

3.51

90.38

1.4

5.74

5.96

u/l

0.19

303

523

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

561

1204

2.72

90.31

1.1

62.80

63.22

au/ml

—

(3024932) HLA-DR beta [Type]

252

310

4.73

89.05

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

348

558

3.63

89.01

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

348

558

3.63

89.01

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

626

1435

2.55

88.86

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

456

878

3.03

88.65

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

303

439

4.02

88.51

2.2

1.4

27.44

29.24

umol/l

2.00

290

421

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

454

874

3.03

88.29

1.1

—

(3024471) HLA-A [Type]

254

321

4.60

87.16

1.0

—

(3003694) ABO and Rh group [Type] in Blood

10666

51335

1.28

86.17

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

207

217

5.54

86.04

1.4

1.1

—

(3023410) Appearance of Cerebral spinal fluid

590

1335

2.58

85.93

1.7

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

477

963

2.89

85.64

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

266

358

4.32

84.97

2.4

1.7

29.69

28.83

0.36

260

339

(3038177) Helicobacter pylori Ab [Presence] in Serum

946

2660

2.08

84.65

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

2864

23858

0.67

84.35

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

270

372

4.22

83.90

2.6

1.8

9.16

10.85

1.13

264

350

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

334

544

3.57

83.63

1.1

1.73

9.45

nmol/l

1.97

132

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

657

1593

2.41

83.13

1.2

1.1

95.85

96.79

0.35

627

1495

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

812

2166

2.19

82.84

1.2

1.1

119.51

117.67

0.76

761

1946

(3026389) Candida sp identified in Specimen by Organism specific culture

680

1704

2.33

80.12

1.5

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

313

504

3.61

79.65

1.7

1.3

20.57

29.68

umol/l

4.77

299

475

(40768441) Liver Pathology biopsy report

459

946

2.83

79.53

1.6

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

930

2662

2.05

79.43

1.4

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

764

2024

2.21

79.24

1.5

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1778

6263

1.67

79.12

1.7

1.6

310.66

292.72

mu/l

1.27

1655

5560

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

332

566

3.41

77.94

1.6

1.5

1686935.85

1267716.32

iu/ml

0.29

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

38.99

76.97

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

736

1945

2.21

76.79

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

988

2941

1.97

75.82

1.8

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

978

2908

1.97

75.29

1.8

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

509

1144

2.59

75.16

1.4

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

458

982

2.72

73.93

2.1

2.0

39.70

38.09

1.23

451

968

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1242

4027

1.81

73.67

1.1

6.64

4.86

u/ml

0.52

172

686

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

374

715

3.05

73.64

1.5

23.27

25.44

u/ml

0.29

146

(3011412) CD3 cells [#/volume] in Blood

469

1024

2.67

73.20

2.5

2.0

1.34

1.11

e9/l

4.40

396

915

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

714

1901

2.19

73.19

1.3

43.84

28.02

u/l

2.22

656

1632

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

249

361

4.01

72.77

1.2

0.31

g/l

0.01

221

279

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1278

4201

1.79

72.47

2.2

1.7

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

106

10.98

72.46

1.1

22.10

20.94

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

106

10.98

72.46

1.1

26.62

15.75

u/ml

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

234

325

4.18

72.09

1.2

111.10

110.31

0.14

212

288

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

431

917

2.74

70.59

3.0

2.3

—

(3024263) Appearance of Synovial fluid

332

605

3.19

70.57

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

408

844

2.82

70.29

2.3

2.2

19.87

18.85

nmol/l

1.10

388

813

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

523

1234

2.47

70.10

1.9

1.7

24.44

29.23

mg/l

0.92

140

386

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

448

979

2.67

69.83

1.5

1.3

12.45

11.93

umol/l

0.67

420

935

(3051611) Lipemic interference index of Serum or Plasma

571

1412

2.36

69.30

4.0

3.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

266

424

3.65

68.71

2.6

1.7

161.91

158.85

0.16

255

391

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

308

544

3.29

68.68

2.7

1.7

143.09

141.42

0.12

294

513

(4094501) Cardiovascular stress test using bicycle ergometer

1179

3854

1.79

68.07

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

799

2297

2.03

67.46

1.1

3.89

2.82

u/ml

0.91

274

1315

(3016018) Differential panel - Cerebral spinal fluid

582

1471

2.31

67.32

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

151

147

5.96

67.28

6.7

4.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1083

3471

1.83

66.64

1.8

1.9

21.77

10.01

iu/l

0.29

314

1335

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

13.63

66.23

3.0

2.2

2.04

2.37

mg/l

0.43

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

318

588

3.15

66.10

1.3

1.2

75.91

103.78

titre

0.29

(3042517) Benzodiazepines panel - Urine

128

105

7.07

65.75

3.3

3.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

417

913

2.66

64.80

1.2

1.1

37.00

44.79

mg/l

2.41

379

729

(3017354) Segmented neutrophils/100 leukocytes in Blood

380

791

2.80

64.78

3.1

2.9

58.82

57.81

0.33

265

679

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

718

2019

2.08

64.26

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

275

471

3.39

64.22

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

238

369

3.75

63.85

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

402

870

2.69

63.85

1.1

235.19

261.59

mg/l

1.89

376

747

(3045142) Bone marrow Pathology biopsy report

526

1301

2.36

63.85

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1949

7408

1.55

63.37

3.0

3.3

44.27

50.86

u/ml

0.41

1867

7176

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

775

2257

2.01

63.20

1.2

1.1

10.92

11.63

au/ml

0.10

187

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

473

1119

2.46

63.10

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1160

3869

1.76

62.59

4.8

2.8

1.53

1.46

mg/l

1.91

1092

3573

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

321

618

3.02

62.56

1.3

1.2

442.22

515.45

titre

0.09

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1301

4487

1.70

62.41

1.2

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

773

2260

2.00

62.37

1.2

248.33

93.33

titre

0.75

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

773

2260

2.00

62.37

1.9

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1159

3869

1.76

62.36

2.0

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

177

220

4.67

62.00

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

373

788

2.75

61.94

4.6

3.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

205

290

4.11

61.84

2.1

1.5

32.26

34.75

u/l

0.09

192

258

(3044941) Cell count panel - Synovial fluid

752

2187

2.01

61.56

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

716

2045

2.04

61.53

1.2

—

(3023419) Bacteria identified in Sputum by Culture

611

1646

2.17

60.92

2.5

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

757

2220

1.99

60.57

1.6

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

289

532

3.16

60.54

6.6

4.1

1242.86

4735.87

mg/l

1.59

243

368

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

218

330

3.84

60.39

2.7

2.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

485

1190

2.37

59.93

1.6

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3059

12861

1.41

59.85

2.4

2.0

12.07

12.75

nmol/l

4.37

2722

11749

(4146454) Self-monitoring of blood glucose

287

535

3.12

58.96

3.0

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2072

8111

1.50

58.76

1.4

1.3

24.88

27.36

iu/l

2.70

1788

6869

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

278

510

3.17

58.57

1.2

—

(3045424) Erythrocytes [Presence] in Urine

688

1976

2.03

58.27

1.5

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

477

1181

2.35

57.81

1.4

1.3

103183.55

95760.05

e6/l

0.09

368

813

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

383

855

2.61

57.41

14.6

11.2

838.36

2002.44

nmol/l

0.50

374

822

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

634

1783

2.07

56.76

1.6

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

396

908

2.54

56.34

1.3

1.2

1.24

2.28

u/ml

1.48

248

403

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

240

412

3.38

55.93

1.3

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

450

1108

2.37

55.23

1.3

1.37

1.41

nmol/l

0.33

406

1001

(3041672) Baker's yeast Ab [Presence] in Serum

12.23

55.01

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

951

3107

1.79

54.99

1.6

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

381

869

2.55

54.79

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

148

175

4.91

54.74

1.9

2.0

17.12

17.09

umol/l

0.01

148

175

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

389

899

2.52

54.50

18.4

16.2

1425.82

3081.78

nmol/l

0.48

381

866

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

349

765

2.65

54.20

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

350

772

2.64

53.72

1.3

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1515

13167

0.65

53.69

4.5

3.7

1.22

mmol/l

0.44

1375

11211

(3035947) Staphylolysin Ab [Units/volume] in Serum

322

680

2.75

53.59

1.2

1.1

3.50

4.28

iu/ml

0.54

(3034426) Prothrombin time (PT)

241

430

3.26

53.05

1.3

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

129

139

5.38

52.41

1.4

1.5

112753.44

499167.84

nmol/l

0.98

102

119

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

318

682

2.71

51.47

1.2

72.92

61.77

u/ml

0.17

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

318

685

2.70

51.06

1.2

54.00

46.34

u/ml

0.17

(1175426) CD3 cells/100 lymphocytes in Blood

367

860

2.48

50.04

2.3

1.9

74.26

72.44

1.36

355

831

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

389

941

2.41

49.64

2.0

1.7

3.51

3.86

mg/l

0.79

373

886

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.97

49.47

1.5

1.7

1.34

2.19

mg/l

0.59

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.97

49.47

1.5

1.7

1.87

1.11

mg/l

0.65

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.97

49.47

1.5

1.7

1.47

3.83

mg/l

1.51

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.97

49.47

1.5

1.7

0.48

0.63

mg/l

0.26

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.97

49.47

1.5

1.7

1.26

2.04

mg/l

0.47

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.97

49.47

1.5

1.7

1.54

1.57

mg/l

0.01

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

7.97

49.47

1.5

1.7

1.02

2.16

mg/l

1.17

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.97

49.47

1.5

1.7

3.76

3.73

mg/l

0.01

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.97

49.47

1.5

1.7

1.42

3.12

mg/l

1.06

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

369

872

2.46

49.45

1.2

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.82

49.35

1.5

1.7

1.56

1.90

mg/l

0.20

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

353

819

2.51

49.12

2.4

1.8

—

(4035726) Immunohistochemistry procedure

3066

13326

1.36

48.65

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

360

848

2.47

48.58

2.3

1.8

14.05

15.46

1.51

354

829

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

303

656

2.68

48.23

1.2

10.70

6.95

u/ml

0.21

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

318

707

2.61

48.14

2.1

1.6

2.30

2.44

u/field

0.09

279

561

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

127

147

5.01

48.08

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

901

3021

1.74

47.75

1.1

5.24

5.75

u/ml

0.31

511

1465

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

449

1181

2.21

47.52

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

185

299

3.59

47.06

1.7

1.3

1307.35

2159.61

u/ml

0.29

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

353

838

2.45

46.90

1.9

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

278

584

2.77

46.78

1.4

1.3

—

(3001186) Copper [Moles/volume] in Serum or Plasma

170

260

3.79

46.59

1.5

1.2

16.91

16.65

umol/l

0.20

153

230

(3041096) Erythrocytes [Presence] in Urine by Automated

6844

46761

0.81

46.34

3.4

2.7

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

174

2925

0.34

46.21

2.6

2.2

13.11

0.01

168

2879

(3021788) Differential panel - Synovial fluid

803

2631

1.78

46.03

1.5

—

(44813793) Dust mix specific IgE antibody measurement

404

1030

2.28

45.98

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

258

525

2.85

45.94

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

293

641

2.66

45.77

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

320

733

2.54

45.73

1.6

1.8

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

9.79

45.61

2.5

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

510

1447

2.05

44.72

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

410

1072

2.23

44.05

3.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

452

1234

2.13

43.75

4.0

5.1

198.02

92.73

u/ml

1.18

117

448

(40768446) Kidney Pathology biopsy report

239

483

2.87

43.11

1.9

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

336

818

2.39

42.39

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

971

3435

1.65

42.35

1.1

1.81

2.39

u/ml

1.03

541

1610

(3014271) Vancomycin [Susceptibility]

212

405

3.04

42.04

2.8

2.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

213

409

3.02

41.89

1.1

87.24

92.15

0.92

185

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

213

411

3.01

41.56

1.2

108.29

106.42

0.23

195

373

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

124

161

4.47

41.54

1.0

—

(3028433) Virus identified in Specimen by Culture

182

318

3.32

41.47

1.2

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

199

369

3.13

41.40

1.1

3.77

7.58

u/ml

0.59

125

213

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

185

328

3.27

41.25

2.0

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

185

328

3.27

41.25

2.0

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

187

334

3.25

41.23

2.0

1.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

208

399

3.03

40.98

1.1

1.2

86.04

92.50

0.96

184

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

154

242

3.69

40.78

2.9

2.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

277

628

2.56

40.47

2.1

2.3

38.51

178.09

ug/l

0.73

267

598

(3051387) C reactive protein [Mass/volume] in Capillary blood

355

4221

0.48

40.32

3.7

3.0

20.56

27.47

mg/l

3.72

171

2777

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

121

158

4.44

40.29

1.7

1.3

71.06

101.26

ng/l

0.39

105

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.06

40.19

1.2

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

119

154

4.48

40.03

1.2

—

(3011985) Renin [Units/volume] in Plasma

572

1760

1.89

40.01

1.6

1.5

66.00

68.04

mu/l

0.06

528

1572

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

168

286

3.41

39.80

1.5

1.3

104.70

106.71

0.27

161

267

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

303

726

2.43

39.58

1.3

1.2

4.95

5.53

umol/l

1.57

275

683

(3027456) Digoxin [Moles/volume] in Serum or Plasma

660

2135

1.80

39.51

3.3

3.0

0.79

0.81

nmol/l

0.41

523

1694

(3008295) Osmolality of Serum or Plasma

438

1233

2.07

39.27

1.5

1.4

280.24

279.26

mosm/kgh2o

0.33

321

970

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.08

39.19

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

896

3172

1.65

38.99

2.2

133.58

116.67

ug/min

0.40

515

1901

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

195

371

3.05

38.97

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

195

372

3.04

38.80

1.4

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

495

1465

1.97

38.77

1.1

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

159

267

3.45

38.43

1.2

74.05

78.86

0.37

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

441

4802

0.53

38.11

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

269

620

2.52

38.07

3.4

3.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

159

269

3.43

38.03

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

232

496

2.72

37.93

1.1

—

(3016038) Potassium [Moles/volume] in Urine

304

748

2.36

37.55

1.4

1.2

37.24

35.40

mmol/l

0.52

259

654

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1316

5143

1.50

37.44

1.9

1.6

41.13

40.13

nmol/l

0.75

1287

5067

(3008401) Mugwort IgE Ab [Units/volume] in Serum

838

2947

1.66

37.42

1.1

0.90

1.22

u/ml

0.94

404

1159

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

111

144

4.47

37.27

1.9

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

504

1524

1.92

37.15

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4238

19929

1.26

37.10

1.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

159

275

3.35

36.85

1.2

85.28

87.37

0.13

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

159

276

3.34

36.65

1.2

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

102

5.23

36.48

1.5

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

159

277

3.33

36.46

1.1

—

(3044927) Protein electrophoresis panel - Urine

333

866

2.23

36.33

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

275

657

2.43

36.19

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

204

419

2.83

35.87

1.4

1.3

57.87

56.62

0.17

177

360

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

771

2683

1.68

35.84

3.6

1.5

0.87

0.82

nmol/l

1.09

646

2363

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

271

646

2.44

35.84

1.1

1.06

1.11

u/l

0.32

306

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6200

30465

1.21

35.79

1.6

1.7

28537219.19

35012708.74

pmol/l

0.44

5358

25234

(3034274) Bile acid [Moles/volume] in Serum --fasting

686

2318

1.72

35.48

2.4

2.2

6.64

6.09

umol/l

0.43

514

1697

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

270

646

2.43

35.44

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

192

384

2.90

35.36

1.8

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

277

3.29

35.34

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

942

3465

1.59

35.18

2.0

1.8

187.87

201.23

pmol/l

3.13

895

3311

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

205

428

2.78

35.03

2.0

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

198

406

2.83

34.94

1.3

75.72

308.27

nmol/24h

1.65

198

406

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

124

187

3.84

34.74

1.6

1.4

0.38

0.46

ug/l

1.05

124

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

204

428

2.77

34.57

2.0

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

306

786

2.26

34.39

1.9

1.5

3.95

6.32

u/l

2.75

268

594

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

126

4.55

34.00

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

111

156

4.12

33.98

2.3

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

172

330

3.02

33.98

1.9

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

418

1224

1.99

33.80

1.9

2.7

1.22

1.30

g/24h

0.19

150

665

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

341

924

2.14

33.76

1.6

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

205

439

2.71

33.48

1.1

550.66

412.53

ng/l

0.20

113

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

155

284

3.17

32.97

1.6

1.5

8.92

9.25

ug/l

0.35

155

284

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

657

2241

1.71

32.89

3.7

3.3

24.98

41.97

u/ml

3.95

634

2157

(3028626) Oxygen [Partial pressure] in Capillary blood

884

3258

1.58

32.77

5.0

2.9

8.58

8.31

kpa

3.82

861

3184

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

123

4.52

32.74

1.1

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

586

1939

1.76

32.62

1.7

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

197

419

2.73

32.60

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

145

260

3.23

31.91

1.2

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

216

489

2.56

31.78

1.5

1.4

418.68

887.55

mu/l

1.29

206

469

(3008536) Aspergillus sp Ab [Presence] in Serum

117

181

3.75

31.75

1.9

2.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

208

462

2.61

31.75

1.0

1.1

8.65

8.18

u/ml

0.07

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

341

949

2.09

31.61

1.4

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

317

858

2.15

31.51

1.5

1.4

13.12

12.42

u/l

0.80

309

834

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

249

610

2.37

31.15

1.0

38.39

41.83

ng/l

0.71

161

470

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

239

575

2.41

31.08

3.7

2.9

8.35

8.48

mg/l

0.10

209

433

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

249

611

2.37

31.05

1.0

742.75

712.06

ng/l

0.47

161

455

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

124

4.39

31.05

1.5

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

247

605

2.37

30.92

1.0

279.51

334.64

ng/l

2.17

164

474

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

174

356

2.84

30.89

1.4

15.83

14.98

pmol/l

0.39

145

306

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

136

239

3.30

30.87

1.2

346.79

332.68

pmol/l

0.09

117

183

(21491868) Cryoglobulin [Mass/volume] in Serum

198

436

2.64

30.75

1.2

1.1

0.72

0.23

g/l

0.63

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

565

5416

0.60

30.69

1.8

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

217

503

2.50

30.48

1.5

1.4

73.04

72.66

0.13

207

483

(3023487) Leukocytes [#/volume] in Peritoneal fluid

195

428

2.64

30.47

2.6

1.6

989.38

2786.16

e6/l

0.57

133

263

(3002079) Sodium [Moles/time] in 24 hour Urine

242

592

2.37

30.39

1.3

1.2

144.46

167.14

mmol/24h

3.83

242

592

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

221

518

2.48

30.36

2.9

2.3

129.03

148.54

au/ml

0.21

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

196

435

2.61

30.00

2.0

1.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

510

1663

1.78

29.87

1.3

1.4

818.09

303.80

pmol/l

1.11

435

1453

(3027231) Wheat IgE Ab [Units/volume] in Serum

141

260

3.14

29.75

1.1

0.48

0.78

u/ml

1.01

121

246

(3006462) Nitrate [Presence] in Urine

268

693

2.25

29.74

2.8

2.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

483

1551

1.81

29.74

1.6

1.4

4283.99

2558.32

e6/l

0.44

369

1055

(37021550) Renin [Units/volume] in Plasma --upright

118

193

3.54

29.73

1.2

1.3

67.96

65.66

mu/l

0.04

150

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

397

1201

1.92

29.34

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

660

2329

1.65

29.18

1.1

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

305

839

2.11

29.17

1.3

1.2

207.43

390.14

u/l

2.61

280

793

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

730

2652

1.60

28.77

3.0

4.0

196.02

1079.89

u/ml

2.50

676

2429

(3036603) Volume of Urine

320

902

2.06

28.75

1.6

2024.05

1937.74

0.86

315

888

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

116

194

3.47

28.35

1.4

1.3

0.26

0.25

nmol/l

0.06

129

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

7.77

28.29

9.3

10.9

127.95

214.36

e6/l

0.74

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

10172

52963

1.15

28.07

4.7

4.4

2.71

3.03

ug/l

0.38

9251

47686

(3010015) Selenium [Moles/volume] in Serum or Plasma

5.14

27.79

2.1

1.7

1.35

1.29

umol/l

0.48

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

101

155

3.78

27.76

2.5

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

567

1949

1.69

27.69

1.4

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

293

812

2.10

27.53

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

237

602

2.29

27.45

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1608

6903

1.36

27.28

2.5

2.4

0.31

0.28

e6/l

0.33

1540

6688

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

310

883

2.04

27.13

1.3

1.2

2.05

2.11

mmol/l

0.26

290

823

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

147

3.82

27.12

1.7

1.4

117.56

121.74

ng/l

0.08

147

(3036071) Salmonella sp Ab [Titer] in Serum

207

497

2.42

27.12

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

140

3.89

26.87

1.3

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

135

3.95

26.80

1.0

0.43

0.69

u/ml

0.23

(3028308) Erythrocytes [#/volume] in Pleural fluid

447

1449

1.79

26.75

1.6

1.4

49489.93

50582.21

e6/l

0.03

310

808

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

223

558

2.32

26.73

1.4

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

133

3.96

26.65

1.7

1.6

—

(3025130) Human papilloma virus identified in Specimen

663

2398

1.61

26.64

1.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

102

164

3.60

26.37

2.0

1.5

43.54

55.34

pmol/l

0.48

136

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

177

400

2.57

26.24

2.6

1.5

20129.56

10382.23

e6/l

0.41

104

189

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

314

914

2.00

25.95

1.1

8.71

9.25

iu/ml

0.12

273

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

219

551

2.31

25.95

1.4

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

5.70

25.93

1.0

0.03

0.11

u/ml

0.44

(3028679) Herpes simplex virus Ab [Presence] in Serum

280

781

2.08

25.92

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

110

189

3.37

25.90

1.1

1.2

10.32

13.68

u/ml

0.22

133

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

449

2.45

25.76

3.6

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

449

2.45

25.76

3.6

2.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

111

4.23

25.67

1.3

41.82

54.25

1.10

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.48

25.41

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

109

191

3.31

24.95

1.1

0.65

0.96

umol/24h

0.47

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

4.53

24.73

1.1

2.74

4.14

u/ml

0.28

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

133

3.83

24.73

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

128

3.89

24.65

1.1

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

201

500

2.33

24.46

2.6

1.8

9.39

9.60

mg/l

0.19

167

379

(3010726) Horse dander IgE Ab [Units/volume] in Serum

770

2945

1.52

24.35

1.1

1.35

2.21

u/ml

2.51

447

1327

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

355

1103

1.87

24.34

2.2

2.0

2.79

1.94

u/field

1.90

263

449

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

133

269

2.87

24.21

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

241

652

2.15

24.13

1.1

1678.70

1448.45

miu/ml

2.07

241

652

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2845

20035

0.81

24.05

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

153

3.56

23.94

4.9

2.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

814

3166

1.50

23.80

3.2

2.9

24.38

24.84

mmol/l

2.44

798

3097

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

497

1720

1.68

23.75

1.4

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

170

397

2.48

23.66

1.9

1.6

174.65

140.54

au/ml

0.26

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

235

635

2.15

23.61

2.4

2.2

74.98

130.64

ug/min

0.51

122

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

714

6111

0.67

23.18

1.4

1.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

9.31

23.14

4.4

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1842

13569

0.77

23.01

1.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

5.17

22.89

1.3

1.4

42.21

35.56

0.40

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

156

3.45

22.73

5.0

2.5

22.36

23.16

mg/l

0.19

146

(3004809) Band form neutrophils/100 leukocytes in Blood

510

1801

1.65

22.61

3.2

2.9

1.12

1.56

2.55

416

1613

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4.68

22.44

1.3

1.1

15.06

13.40

nmol/l

0.32

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

168

401

2.43

22.38

1.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

4.20

22.36

1.0

1.1

1.35

12.44

u/ml

1.40

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.41

22.35

2.2

1.8

—

(1002224) Polysomnography panel

1688

7519

1.31

22.33

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

207

544

2.21

22.28

1.7

1.5

25.47

5.02

nmol/l

0.43

189

455

(3045788) Cell count panel - Pleural fluid

386

1269

1.77

22.15

1.6

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1616

7178

1.32

21.81

2.1

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8204

42691

1.14

21.79

1.6

1.42

1.36

mmol/l

6.07

7487

34927

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

478

1677

1.66

21.75

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

475

4367

0.62

21.71

4.9

3.7

4.99

5.00

kpa

0.05

462

4272

(3012501) Base excess in Blood by calculation

475

4367

0.62

21.71

4.9

3.7

2.26

2.49

mmol/l

1.29

321

2935

(3047189) Immunofixation for 24 hour Urine

208

554

2.18

21.70

1.6

1.9

—

(3007463) Buprenorphine [Presence] in Urine

6.05

21.47

3.7

12.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

194

504

2.23

21.47

1.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

622

2335

1.55

21.46

1.3

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

9.37

21.35

4.2

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4110

20327

1.19

21.16

1.5

1.4

—

(3044007) Cell count panel - Peritoneal fluid

160

384

2.42

21.11

2.2

1.6

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

14.21

20.95

6.4

1.1

—

(3002619) Bacteria identified in Specimen by Culture

131

286

2.66

20.86

1.3

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

5.04

20.83

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

344

1115

1.79

20.73

1.1

—

(40757373) Influenza virus identified in Isolate

103

197

3.03

20.67

2.0

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1605

7185

1.30

20.48

1.6

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

485

4377

0.64

20.42

4.8

3.7

8.67

8.66

kpa

0.05

472

4282

(3006270) Folate [Moles/volume] in Blood

337

1091

1.79

20.40

1.2

1.1

373.32

396.50

nmol/l

1.12

292

924

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

142

3.43

20.35

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

693

2695

1.50

20.35

1.5

1.4

0.45

0.43

nmol/l

0.16

540

2145

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

151

359

2.44

20.34

1.0

8.66

11.53

u/ml

0.78

237

(3003434) Protein [Mass/volume] in Pleural fluid

493

1775

1.61

20.31

1.5

1.4

32.90

33.76

g/l

0.70

450

1600

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

173

442

2.27

19.94

2.7

2.8

29.30

28.36

umol/l

0.45

127

335

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

4.31

19.86

1.1

1.2

1.37

1.25

ml/s/173m2

0.33

(3009871) Measles virus Ab [Titer] in Serum

176

455

2.24

19.75

1.5

1.7

—

(40765096) Chromosome analysis panel by Banding

132

298

2.57

19.75

1.1

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

5.01

19.54

1.3

1.4

13.78

14.58

0.08

(43055514) Macroprolactin [Presence] in Serum or Plasma

151

367

2.39

19.44

1.5

1.4

—

(3018133) Calcium [Moles/volume] in Urine

153

3.26

19.35

2.3

1.7

2.81

2.63

mmol/l

0.26

138

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1478

6599

1.31

19.24

1.8

1.6

3.96

3.70

mg/l

0.39

1149

4500

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8108

42456

1.13

19.16

4.1

3.9

22.62

21.89

3.52

3847

19418

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1355

5988

1.32

18.99

1.4

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

127

287

2.56

18.98

1.4

1.2

136.68

126.46

nmol/l

0.23

203

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1354

5994

1.32

18.75

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1346

5956

1.32

18.70

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

122

273

2.59

18.60

1.4

1.2

25.07

47.91

g/l

0.58

221

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

807

3303

1.42

18.26

1.5

1.4

144.18

129.31

pmol/l

0.22

785

3238

(3030313) Adrenal Ab [Titer] in Serum

102

3.75

18.13

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1345

5980

1.31

18.07

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

177

478

2.15

17.96

8.1

13.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

130

306

2.46

17.94

1.3

1.2

40.04

40.83

g/l

0.22

167

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.30

17.92

2.4

2.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

198

560

2.05

17.87

2.4

2.3

48.14

50.90

umol/l

0.58

171

470

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

137

333

2.38

17.69

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

116

260

2.59

17.66

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

875

3657

1.39

17.59

1.2

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

446

1625

1.59

17.59

2.1

1.8

24.59

27.07

ug/l

0.28

431

1605

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

17.46

1.0

0.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

155

3.10

17.38

2.3

2.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

612

2403

1.48

17.23

1.1

89.15

816.57

iu/ml

0.96

110

513

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

112

250

2.60

17.20

2.0

1.9

2.32

4.54

ug/l

0.62

164

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

4.26

17.10

1.4

1.3

14.85

16.53

pmol/l

0.24

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

251

2.59

17.07

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

5.08

16.77

1.2

25.40

24.71

u/ml

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.11

16.71

2.1

1.6

47.81

43.54

umol/l

0.40

(3019977) pH of Arterial blood

264

846

1.81

16.63

3.2

2.4

7.42

0.07

348

(3033799) Differential panel - Peritoneal fluid

157

417

2.18

16.63

2.3

1.7

—

(3022229) Phosphate [Moles/volume] in Urine

5.27

16.59

2.8

1.7

20.18

21.71

mmol/l

0.17

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

347

2.31

16.59

1.1

—

(3020491) Glucose [Moles/volume] in Blood

319

1082

1.71

16.59

2.0

1.9

6.36

6.70

mmol/l

1.39

273

872

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

182

2.86

16.56

1.0

1.7

—

48.50

—

(3028271) Lactate [Moles/volume] in Capillary blood

309

2936

0.61

16.39

2.1

1.7

1.71

1.78

mmol/l

0.50

299

2871

(3026692) Albumin [Mass/volume] in Peritoneal fluid

130

320

2.35

16.38

2.0

1.2

12.54

13.36

g/l

0.41

243

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

111

3.39

15.62

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

276

915

1.75

15.58

1.1

1.2

1.06

1.07

ratio

0.37

424

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

4.32

15.43

1.3

1.5

1.32

1.16

u/field

0.33

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

221

687

1.87

15.36

1.2

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

149

2.99

15.29

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

126

316

2.31

15.28

1.1

7.01

6.16

mg/g

0.81

121

303

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

202

612

1.91

15.16

1.2

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.93

15.15

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

150

2.97

15.13

1.4

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

126

318

2.30

15.07

2.4

1.9

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

154

2.93

14.99

1.2

1.3

36.54

48.05

mg/l

1.13

130

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

124

313

2.30

14.84

1.2

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

4.00

14.68

1.0

0.39

0.30

u/ml

0.20

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

4.50

14.47

1.2

1.3

1.61

0.98

0.41

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

212

666

1.85

14.30

1.1

94.85

96.04

0.23

171

514

(40767503) Oxygen content in Capillary blood by calculation

451

3821

0.68

14.04

2.6

2.3

16.56

16.62

0.12

271

1761

(3010503) CD19 cells [#/volume] in Blood

215

684

1.82

13.96

2.6

2.2

0.22

e9/l

0.02

207

668

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

208

658

1.83

13.76

7.1

4.5

14303.02

1523.52

u/ml

0.47

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

110

3.21

13.58

1.3

1.2

46.49

49.57

mg/l

0.19

(3005011) Chlamydia sp Ab [Titer] in Serum

187

2.63

13.53

1.7

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.66

13.44

1.4

1.3

5.90

5.67

mmol/l

0.08

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1371

6357

1.26

13.32

1.4

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

131

357

2.13

13.15

1.9

1.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

227

750

1.76

13.06

1.2

1.1

196.24

216.62

iu/ml

0.40

227

740

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

104

3.23

13.04

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

238

798

1.73

13.02

6.5

7.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.80

13.00

1.0

1.1

0.24

4.18

u/ml

1.82

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

4.56

12.95

1.0

0.12

2.50

u/ml

0.52

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

162

2.72

12.85

3.3

2.5

80.57

69.14

pmol/l

0.23

145

(3010421) pH of Blood

618

4875

0.73

12.71

4.7

3.6

7.42

1.77

489

4603

(3002621) Streptococcal DNAse B [Units/volume] in Serum

107

3.14

12.50

1.1

—

(3014891) Appearance of Pleural fluid

132

2.90

12.49

1.3

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

213

2.45

12.45

1.1

1.0

80.37

77.43

ug/l

0.27

180

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.02

12.44

3.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.79

12.40

6.2

4.9

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

3.45

12.38

1.0

1.1

9.68

7.39

u/ml

0.09

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

149

2.76

12.36

3.7

2.8

42.72

45.90

umol/l

0.49

130

(3032352) Blasts [#/volume] in Cerebral spinal fluid

112

3.05

12.17

2.9

2.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

5.59

12.02

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.69

11.98

4.1

2.9

83.81

59.98

pmol/l

0.15

(3017461) Flecainide [Moles/volume] in Serum or Plasma

3.89

11.95

1.7

1.4

0.72

0.71

umol/l

0.04

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

163

502

1.88

11.79

2.4

139.51

148.36

nmol/l

0.52

153

405

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

999

4528

1.28

11.75

1.9

1.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

152

2.67

11.49

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

3.00

11.48

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

105

278

2.19

11.38

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

304

1127

1.56

11.35

1.1

3.31

2.17

u/ml

0.22

120

326

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

4.72

11.30

4.5

5.5

19.66

17.50

mmol/l

0.74

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

195

2.44

11.28

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

314

1176

1.55

11.22

1.3

810.20

514.02

u/l

0.58

300

1116

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

143

429

1.93

11.20

2.9

2.6

1.36

1.20

ug/l

0.36

134

401

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

105

280

2.17

11.19

1.2

1.1

—

(3048879) Bone marrow aspiration report

203

2.40

11.17

2.0

1.6

—

(3017509) Phencyclidine [Presence] in Urine

194

2.42

10.99

2.6

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

104

280

2.15

10.85

1.2

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2750

18158

0.87

10.78

3.5

3.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

158

2.57

10.71

1.6

114.23

109.58

ug/l

0.13

126

(4034850) Laboratory test

931

6782

0.79

10.66

13.3

8.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

136

2.68

10.49

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

185

2.41

10.40

1.9

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

3.31

10.34

1.0

1.1

0.16

0.37

u/ml

0.34

(3012441) Differential panel - Pleural fluid

368

1453

1.47

10.31

1.5

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

3.13

10.15

1.0

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

132

2.68

10.13

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

103

2.92

10.08

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

2265

11326

1.17

10.07

4.3

3.6

1.12

0.99

1.15

965

3557

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

153

2.54

10.05

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.63

10.02

8.7

7.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.46

10.02

1.3

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

498

2090

1.38

10.00

1.1

1.0

0.24

0.56

u/ml

1.36

160

430

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

3.13

9.97

1.0

1.1

0.74

1.61

u/ml

0.31

(3014599) Egg white IgE Ab [Units/volume] in Serum

295

1123

1.52

9.87

1.1

2.09

4.30

u/ml

0.40

263

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.10

9.80

2.0

1.2

329.57

319.38

umol/24h

0.09

(3001556) Androgen free Index in Serum or Plasma

118

2.75

9.77

1.3

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

145

2.56

9.76

1.7

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

102

2.89

9.74

1.1

1.2

1.60

1.70

umol/24h

0.27

102

(3007930) Methemoglobin/Hemoglobin.total in Blood

1019

4747

1.25

9.62

5.3

4.5

0.86

0.91

2.79

983

4396

(3027923) C peptide [Moles/volume] in Serum or Plasma

159

523

1.76

9.44

1.6

1.25

1.24

nmol/l

0.04

114

437

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1007

0.50

9.32

1.6

1.4

—

(3020650) Glucose [Presence] in Urine

635

0.38

9.30

1.6

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

142

2.53

9.28

2.1

2.0

0.75

1.55

mmol/l

2.76

111

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5841

31123

1.10

9.26

2.8

0.65

0.78

ug/l

16.42

4176

19049

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

148

480

1.79

9.22

1.2

1.1

—

(3017704) Immunofixation for Urine

153

504

1.76

9.07

1.7

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.09

9.06

1.1

279.24

271.42

nmol/l

0.05

(40768806) Pleura Pathology biopsy report

363

1468

1.43

9.05

1.6

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

586

2566

1.33

9.01

1.1

1.0

3.46

4.44

u/ml

0.84

280

1142

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.96

8.95

1.2

1.6

1.10

9.71

u/ml

0.64

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1008

0.52

8.94

1.6

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

111

2.71

8.90

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

292

1136

1.49

8.88

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1021

4812

1.23

8.72

5.1

4.5

1.71

1.68

0.33

982

4460

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.96

8.40

1.3

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

275

2.00

8.35

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.01

8.19

1.3

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.73

8.10

1.5

1.1

2.18

0.42

umol/24h

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

251

2.03

8.06

1.3

1.4

5.29

5.95

nmol/l

0.75

244

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.86

7.94

1.2

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.44

7.90

1.2

1.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

9.84

7.86

1.1

1.51

1.22

mg/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

149

1401

0.61

7.86

1.7

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

134

445

1.74

7.80

6.6

5.4

24.62

25.01

mmol/l

0.47

128

391

(4212803) Bone marrow aspirate examination

123

2.49

7.79

1.1

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.60

7.49

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

777

3619

1.25

7.46

1.8

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

411

1759

1.36

7.45

1.9

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.76

7.31

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

324

1340

1.40

7.24

1.4

1.3

6.21

6.07

mmol/l

0.33

302

1238

(3023430) Cat dander IgE Ab [Units/volume] in Serum

546

2456

1.29

7.02

1.1

1.0

3.94

5.78

u/ml

1.75

224

974

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.86

7.01

1.0

0.33

0.93

u/ml

0.42

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

350

1476

1.38

6.99

1.5

26.97

31.70

1.86

259

914

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.22

6.86

1.2

1.1

49.71

16.53

—

(3013637) Mi-2 Ab [Presence] in Serum

243

1.95

6.84

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

243

1.95

6.84

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

243

1.95

6.84

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

243

1.95

6.84

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

288

1180

1.41

6.82

2.7

2.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.75

6.80

1.0

215.12

221.25

pmol/l

0.02

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.82

6.67

1.3

1.1

—

(3019174) dRVVT (LA screen)

101

2.52

6.67

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.85

6.64

1.3

1.4

—

(3000012) Reticulocyte production index

272

2187

0.72

6.56

2.3

2.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

127

2.32

6.54

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

167

621

1.56

6.39

1.2

1.1

31.38

22.47

u/l

0.75

156

549

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

363

1564

1.35

6.38

1.2

1.1

3.29

2.06

iu/ml

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

2.99

6.36

1.5

1.6

203.44

188.09

ng/l

0.54

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

167

623

1.55

6.31

1.2

1.1

96.16

83.23

u/l

0.71

158

545

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

4.23

6.22

1.0

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

143

518

1.60

6.13

1.2

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

257

1054

1.41

6.11

1.1

1.0

2.12

0.77

u/ml

0.34

216

(3016031) Almond IgE Ab [Units/volume] in Serum

2.59

6.08

1.0

1.02

1.17

u/ml

0.09

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

121

2.30

6.03

1.2

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

248

1986

0.72

5.89

2.2

32.20

32.75

1.12

248

1970

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

2.32

5.89

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

118

1086

0.63

5.81

1.5

1.4

—

(40758292) HTLV I+II Ab panel - Serum

227

1.89

5.67

1.2

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

136

2.17

5.66

2.6

2.4

1.03

1.30

mg/l

0.54

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

257

1.82

5.61

1.1

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

100

2.37

5.55

1.3

1.2

436.77

219.10

mg/24h

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

181

711

1.47

5.45

1.1

1.2

1.89

20.23

u/ml

1.62

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

101

2.35

5.45

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.53

5.41

1.1

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

230

947

1.41

5.41

1.2

15.34

14.43

u/l

0.16

216

896

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

124

2.19

5.36

5.9

7.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

308

1.73

5.36

1.3

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

128

2.17

5.34

3.6

7.1

49.81

65.38

g/mol

0.34

123

(3035880) pH of Pleural fluid

187

743

1.46

5.33

1.3

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

175

1.98

5.33

1.1

10.74

12.38

pmol/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

599

2824

1.23

5.29

1.4

1.3

3.25

4.06

ug/l

1.43

534

2568

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.34

5.27

3.5

2.1

16.32

16.30

0.00

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.79

5.25

5.7

4.1

—

(3044009) aPTT.lupus sensitive (LA screen)

118

2.21

5.22

1.2

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

2.64

5.19

1.0

1.68

0.26

u/ml

0.63

(3013336) Amino acids [Identifier] in Serum or Plasma

3.93

5.14

2.6

2.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

9.09

5.08

1.3

1.6

—

(40759632) Porphyrins [Mass/mass] in Stool

9.09

5.08

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.34

5.08

4.0

2.6

1.72

1.69

mu/l

0.02

(3020618) Glucose [Moles/volume] in Synovial fluid

3.28

5.02

1.0

1.1

5.48

4.84

mmol/l

0.24

(3007700) Barley IgE Ab [Units/volume] in Serum

2.79

5.00

1.0

0.94

0.17

u/ml

0.46

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

147

564

1.51

5.00

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

747

3622

1.20

4.99

1.8

2.2

130.49

131.51

g/l

0.44

440

2825

(3025296) Carrot IgE Ab [Units/volume] in Serum

4.03

4.98

1.1

1.0

3.38

0.11

u/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

123

2.12

4.76

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

163

647

1.46

4.73

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.42

4.70

1.1

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

3.33

4.65

1.1

1.0

0.23

0.06

u/ml

—

(37019676) Renin [Units/volume] in Plasma --supine

4.82

4.61

1.1

1.0

82.77

23.20

mu/l

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

241

1.75

4.53

1.6

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

3.04

4.49

1.0

0.06

0.03

u/ml

—

(3024869) Neuronal Ab [Presence] in Serum

189

1.84

4.34

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

2.96

4.33

1.1

1.0

0.11

0.06

u/ml

—

(3013862) HLA-DP [Type]

3.39

4.28

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

225

1.75

4.22

1.3

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.40

4.10

1.1

1.0

92.79

48.95

u/l

0.47

(3017958) Strawberry IgE Ab [Units/volume] in Serum

3.16

4.10

1.0

0.04

0.06

u/ml

0.22

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.29

4.09

4.7

6.8

76.52

71.63

0.47

(3005570) Glucose [Moles/volume] in Urine

219

942

1.35

4.07

1.9

1.7

—

8.12

—

(3026470) Cobalt [Mass/volume] in Blood

184

770

1.38

4.06

1.8

2.0

3.54

3.49

ug/l

0.04

166

708

(3041184) Isoniazid [Presence] in Urine

5.79

3.99

3.3

2.1

—

(3000285) Sodium [Moles/volume] in Blood

153

1.89

3.98

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

181

760

1.38

3.93

1.8

2.1

2.23

2.31

ug/l

0.11

141

658

(40763590) HLA-DQ beta [Type]

3.31

3.90

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

185

784

1.37

3.81

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.53

3.78

1.5

0.25

0.38

u/l

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.98

3.76

1.9

2.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.11

3.74

1.1

6.14

12.56

u/l

1.37

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

363

1690

1.24

3.74

1.4

9.66

7.86

mmol/l

8.51

352

1626

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

662

0.63

3.70

6.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

662

0.63

3.70

3.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.63

3.68

1.5

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.27

3.67

1.2

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.60

3.66

1.3

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.60

3.66

1.4

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.23

3.64

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.23

3.64

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

133

1081

0.71

3.64

1.2

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.82

3.64

1.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

4.18

3.64

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

335

1.56

3.63

1.2

207.24

195.84

ug/l

0.04

173

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

4.90

3.56

1.0

1.1

—

(40760410) HLA-B [Type] by High resolution

3.09

3.54

1.0

—

(40760409) HLA-A [Type] by High resolution

3.09

3.54

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.09

3.54

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.21

3.53

7.7

9.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

334

2384

0.81

3.49

2.1

1.7

91.10

89.66

5.12

329

2347

(3001686) Cold agglutinin [Titer] in Serum or Plasma

195

1.72

3.47

1.6

1.2

46.75

186.10

titre

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

127

514

1.43

3.45

1.0

—

(3049233) Organic acids panel - Urine

5.26

3.45

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.26

3.45

1.5

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

120

1.93

3.42

1.1

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.89

3.41

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

544

3701

0.85

3.40

1.6

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

167

1.77

3.35

1.6

1.7

1.73

1.84

mg/l

0.22

137

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.23

3.33

1.0

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

224

1001

1.30

3.28

4.1

3.3

31.32

70.20

u/ml

4.06

213

994

(3044590) Delta aminolevulinate [Moles/volume] in Urine

6.61

3.27

1.0

1.1

10.50

22.14

umol/l

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

124

506

1.42

3.25

1.4

51.22

62.63

2.71

102

429

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

8.10

3.22

4.0

8.0

12.29

3.80

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.99

3.19

1.0

0.02

0.08

u/ml

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

107

1.95

3.18

1.3

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.23

3.08

1.1

2.68

4.40

u/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

619

3100

1.16

2.98

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

227

1.61

2.98

1.3

21.33

22.20

0.08

186

(3021440) Promyelocytes/100 leukocytes in Blood

2029

10862

1.08

2.97

4.4

3.6

0.20

0.13

2.56

743

3105

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

349

2430

0.83

2.91

1.3

7.06

6.94

mmol/l

0.38

315

2165

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

242

1.58

2.91

1.3

1.2

—

(3009883) Potato IgE Ab [Units/volume] in Serum

4.13

2.89

1.0

0.26

0.05

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

617

3101

1.15

2.85

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

112

1.86

2.82

1.3

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.14

2.81

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.01

2.80

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.65

2.79

1.7

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

361

1739

1.20

2.79

1.6

1.5

54.21

57.22

0.70

245

1087

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.23

2.76

8.3

4.2

—

(3003157) Bacteria [#/volume] in Mother's milk

2.71

2.74

7.8

5.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

105

1.87

2.73

1.1

1.2

113.78

112.16

ug/l

0.02

(3032641) Amino acids panel - Urine

3.86

2.73

1.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

1.91

2.72

1.3

1.2

—

(3004451) EKG impression Narrative

765

0.71

2.71

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.79

2.70

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

294

1.50

2.68

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.57

2.66

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

278

1958

0.82

2.65

10.9

6.1

7.44

7.09

mmol/l

0.64

217

1611

(3005082) Progesterone [Moles/volume] in Serum or Plasma

246

1146

1.24

2.65

1.4

29.49

32.99

nmol/l

1.19

224

1071

(3046861) Legionella sp Ag [Presence] in Urine

110

0.32

2.64

1.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

6.94

2.62

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.21

2.58

1.3

1.6

35.37

17.89

nmol/l

0.61

(3051101) Glucose [Moles/volume] in Cord blood

300

0.56

2.51

5.9

6.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

100

415

1.39

2.48

1.4

29.04

22.00

1.35

377

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

343

0.59

2.48

1.3

1.2

—

(3012565) Volume of 24 hour Urine

118

910

0.75

2.44

2.1

2.2

2075.55

2002.59

0.27

108

829

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

180

1.61

2.43

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.03

2.34

1.0

1.3

—

(3001218) Citrate [Mass/time] in 24 hour Urine

3.03

2.34

1.1

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

133

1.70

2.33

1.4

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

3.21

2.31

1.5

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.95

2.30

1.0

1.1

5.29

8.52

u/ml

0.44

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.81

2.30

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

281

1.46

2.29

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

328

0.60

2.29

2.2

2.7

6.81

7.25

mmol/l

0.43

162

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

204

950

1.24

2.27

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.06

2.22

1.7

1.9

—

(3034614) HLA Ag [Interpretation]

2.67

2.16

1.4

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.90

2.16

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

138

1.64

2.07

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.13

2.07

1.3

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.38

2.05

1.1

1.0

—

(4281824) Cell count and differential, peritoneal fluid

355

1762

1.17

2.05

1.2

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.06

2.02

1.6

1.0

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

2.28

2.02

1.9

1.2

0.32

0.63

0.70

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

2.08

1.98

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

4.34

1.98

1.2

1.0

2045.00

1243.75

titre

—

(3015350) Toxocara sp Ab [Presence] in Serum

3.68

1.97

1.0

—

(3021901) Oxygen saturation in Capillary blood

505

2580

1.13

1.96

2.8

2.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.23

1.92

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

180

1.51

1.84

2.1

2.4

2.88

3.97

ug/l

1.04

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.55

1.84

1.2

1.1

2.27

2.36

0.05

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.10

1.81

1.1

—

(3047181) Lactate [Moles/volume] in Blood

756

3973

1.10

1.81

6.3

4.9

1.28

1.29

mmol/l

0.05

695

3416

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.84

1.78

1.1

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.28

1.76

1.2

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.97

1.73

9.1

4.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

144

670

1.24

1.70

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

115

1.61

1.66

1.1

1.2

1091.50

77.11

u/l

0.46

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.13

1.65

2.9

1.4

162.86

123.42

ug/l

—

(3017569) Oxygen content in Arterial blood

108

488

1.28

1.64

1.8

2.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

422

1.30

1.64

1.1

1.3

21.11

20.23

0.04

(3018291) Platelet Ab [Presence] in Serum

2.36

1.60

1.2

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.36

1.60

1.0

—

(3013762) Body weight Measured

1.97

1.57

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.02

1.56

1.1

1.3

348.63

491.18

nmol/l

0.68

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

252

1251

1.17

1.54

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

271

1.37

1.53

2.3

2.7

—

(40768793) Breast Pathology biopsy report

633

3337

1.10

1.49

1.3

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

135

0.51

1.48

3.6

1.9

16.00

19.43

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

312

1582

1.14

1.45

3.1

2.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1090

5885

1.07

1.45

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.74

1.44

1.2

1.1

—

(3027874) Urate [Moles/volume] in Urine

1.86

1.43

1.1

1.30

14.34

mmol/l

0.51

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

201

1.41

1.43

1.1

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.37

1.42

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.31

1.42

1.2

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

2.89

1.41

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

1.38

0.0

2.4

—

(3035933) Granulocytes/100 leukocytes in Blood

115

537

1.24

1.38

2.0

1.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.73

1.36

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.89

1.24

1.0

1.1

—

(1616796) Gas panel - Central venous blood

707

3789

1.08

1.20

3.5

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.81

1.19

1.1

0.05

0.08

g/l

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.51

1.19

1.4

1.2

1.43

1.41

—

(3016228) CD19 cells/100 cells in Blood

109

517

1.22

1.17

1.9

8.54

7.90

0.24

104

506

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

153

0.60

1.17

3.0

2.1

56.56

56.66

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.53

1.17

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.53

1.17

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.53

1.17

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.53

1.17

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.53

1.17

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.53

1.17

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1886

10431

1.05

1.17

1.6

—

(3008607) Semen analysis panel

156

1.41

1.15

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

145

0.60

1.15

9.9

6.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.54

1.14

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

176

1.38

1.13

1.1

1.2

1.00

1.54

mmol/l

0.51

107

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.63

1.13

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.63

1.13

1.4

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

124

599

1.20

1.12

4.2

3.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.64

1.12

1.3

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

472

2977

0.92

1.08

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

517

2752

1.09

1.07

4.1

2.7

1.55

1.64

mmol/l

1.40

507

2694

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.93

1.06

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

290

1.28

1.05

1.2

176.22

36.21

mg/l

0.71

214

(3024316) Viscosity of Plasma

1.59

1.02

1.4

1.9

1.61

1.97

mpas

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

116

794

0.84

1.01

1.6

1.4

3.92

4.29

0.10

203

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

413

0.78

1.00

1.1

1.2

—

(3009992) Blasts/100 cells in Bone marrow

2.48

0.98

1.7

23.83

12.93

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

132

1.40

0.97

1.1

20.40

20.14

u/l

0.03

(21494814) CD8 cells/100 lymphocytes in Specimen

104

506

1.19

0.92

2.0

1.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

250

1.27

0.91

7.8

5.8

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.85

0.86

1.0

—

(36303858) Crystals [Presence] in Urine

1.78

0.83

1.5

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

261

1665

0.91

0.83

1.4

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

322

1.22

0.82

1.3

41.69

38.81

0.22

232

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1942

11623

0.96

0.80

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.68

0.75

1.0

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.84

0.74

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

208

1.25

0.70

1.6

1.5

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.54

0.70

1.0

161.80

166.46

g/l

—

(44786800) Granulocytes/100 leukocytes in Body fluid

180

0.74

0.69

1.3

1.4

29.87

24.55

0.28

138

(3038515) Glucose [Moles/volume] in Venous blood

489

2656

1.07

0.68

4.2

2.7

7.43

7.72

mmol/l

1.04

481

2605

(40768800) Prostate Pathology biopsy report

515

3164

0.94

0.68

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

230

1.23

0.67

1.0

—

(3025159) Blasts/100 leukocytes in Blood

1864

10456

1.03

0.67

4.4

3.7

0.12

0.26

1.18

592

2741

(46235168) Fasting glucose [Moles/volume] in Blood

231

1.23

0.65

1.3

2.2

7.14

7.00

mmol/l

0.07

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

121

620

1.13

0.62

1.1

1.3

46.80

68.26

1.51

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.83

0.60

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.74

0.58

1.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.53

0.56

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

115

593

1.12

0.55

3.0

—

(3003577) Lead [Moles/volume] in Blood

142

1.26

0.55

1.2

1.6

0.10

0.24

umol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

580

3518

0.95

0.53

5.3

3.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

275

1.18

0.53

2.7

2.4

58.26

30.58

mg/l

0.47

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

191

1.21

0.51

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

357

1.15

0.51

2.8

2.2

120.09

93.66

ng/l

0.67

163

(3012989) Citrate [Moles/time] in 24 hour Urine

1.56

0.49

2.9

1.2

1.83

2.23

mmol/24h

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.32

0.45

2.8

3.7

—

0.00

—

(40762887) Creatinine [Moles/volume] in Blood

1.70

0.44

1.6

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

110

1.26

0.44

1.6

1.4

86.67

59.59

titre

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.45

0.44

1.2

1.0

—

mmol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.61

0.43

2.4

2.9

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

229

0.83

0.43

1.4

12.60

10.48

—

133

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.43

0.0

1.3

—

141.89

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.41

0.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

101

1.26

0.41

5.8

4.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.30

0.37

1.0

—

(40758358) Immune stain study

1.38

0.36

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

212

0.85

0.36

1.1

1.2

20.80

20.43

mmol/l

0.27

174

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.71

0.36

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.28

0.36

1.1

1.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1842

10453

1.02

0.35

4.1

3.5

0.66

0.68

0.11

735

3001

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

303

1.13

0.35

7.8

6.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

109

1.22

0.34

1.0

1.1

—

(3006598) pH of Arterial cord blood

141

0.82

0.33

1.1

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

482

1.09

0.32

1.5

1.4

3.33

2.50

0.33

412

(3052592) Norovirus Ag [Presence] in Stool

235

1.13

0.31

1.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.31

0.31

1.0

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

137

0.84

0.26

1.1

1.0

-2.70

-1.99

mmol/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.21

0.25

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

195

1.13

0.25

2.3

2.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

463

0.92

0.24

1.8

1.9

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.38

0.24

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.83

0.23

1.1

1.5

—

(40768795) Lymph node Pathology biopsy report

301

1682

1.04

0.22

1.3

1.2

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

189

1142

0.96

0.22

1.1

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

225

1.11

0.22

2.4

3.0

573.57

1729.94

u/l

1.22

206

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.21

0.0

1.3

—

1.38

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

134

0.86

0.21

1.1

19.80

16.20

iu/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

393

0.93

0.21

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.16

0.18

5.6

5.8

0.31

0.23

mmol/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.22

0.18

1.2

1.1

8.27

8.77

mmol/l

0.48

(3010937) Rubella virus Ab [Presence] in Serum

113

1.13

0.16

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

165

989

0.96

0.15

1.7

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

208

1170

1.03

0.13

2.2

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

242

0.93

0.13

1.1

1.2

2.06

1.67

mmol/l

0.44

139

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

292

1653

1.02

0.12

1.5

1.3

164.88

199.13

pmol/l

1.33

292

1653

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.16

0.10

1.0

1.1

—

(3001729) Color of Synovial fluid

132

0.92

0.09

1.2

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

255

0.95

0.08

5.1

4.6

47.70

50.85

ug/min

0.12

210

(3022670) pH of Venous cord blood

1.05

0.07

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

101

0.92

0.07

1.1

1.0

—

(40763791) Oxygen content in Venous blood by calculation

1.13

0.07

4.5

6.1

11.23

11.87

ml/dl

—

(3042631) Mycobacterium sp identified in Specimen

342

1954

1.01

0.07

3.0

2.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

928

5346

1.00

0.04

1.5

—

(3005033) Fetal Nuchal fold Thickness US

900

5226

1.00

0.03

1.4

1.5

—

(3039000) Anion gap in Blood

483

2782

1.00

0.02

7.7

5.8

10.96

11.33

mmol/l

1.91

455

2465

(3018572) Chloride [Moles/volume] in Blood

483

2783

1.00

0.02

7.7

5.8

105.08

105.03

mmol/l

0.08

455

2466

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

202

0.97

0.02

1.8

3.3

—

(3015183) Erythrocyte sedimentation rate

165

962

0.99

0.02

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.07

0.02

1.3

1.1

—

(3016750) Collection duration of Urine

145

832

1.01

0.02

2.5

1.9

501.17

502.75

min

0.07

129

559

(3044242) Glucose [Moles/volume] in Arterial blood

572

0.99

0.01

1.5

2.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

189

0.98

0.00

6.4

6.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

904

5235

1.00

0.00

1.4

1.5

—

(3004775) Volume in Urine collected for unspecified duration

194

1126

1.00

0.00

2.6

2.0

682.43

702.49

0.29

155

699

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

546

1.01

0.00

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

467

2705

1.00

0.00

3.9

2.8

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

118

0.98

0.00

1.1

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

200

0.98

0.00

1.4

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.01

0.00

1.1

1.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

12.46

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.8

—

3.40

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_EXAM_OBSER_OTH_REASO – Examination and observation for other reasons

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Examination and observation for other reasons

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Examination and observation for other reasons (Z21_EXAM_OBSER_OTH_REASO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints